Terminology
This
page
is
part
of
the
FHIR
Specification
(v5.0.0:
R5
-
STU
v6.0.0-ballot3:
Release
6
Ballot
(3rd
Draft)
(see
Ballot
Notes
).
This
is
the
The
current
published
version
in
it's
permanent
home
(it
will
always
be
available
at
this
URL).
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
R2
|
Orders
and
Observations
Work
Group
|
Maturity Level : 1 | Draft |
Use
Context
:
Country:
|
Official
URL
:
http://hl7.org/fhir/ValueSet/observation-codes
|
Version
:
|
|||
|
draft
as
of
|
Computable Name : LOINCCodes | |||
|
Flags
:
|
OID : 2.16.840.1.113883.4.642.3.396 | |||
This value set is used in the following places:
This value set includes all LOINC codes
Generated Narrative: ValueSet observation-codes
Last updated: 2025-04-01T12:16:37.966+11:00
Profile: Shareable ValueSet
http://loinc.org
This
expansion
generated
26
Mar
2023
01
Apr
2025
ValueSet
Expansion from tx.fhir.org based on Loinc v2.80
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
| Code | System | Display |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100002-5
|
http://loinc.org | Specimen care is maintained |
|
100003-3
|
http://loinc.org | Team communication is maintained throughout care |
|
100004-1
|
http://loinc.org | Demonstrates knowledge of the expected psychosocial responses to the procedure |
|
100005-8
|
http://loinc.org | Demonstrates knowledge of nutritional management related to the procedure |
|
100006-6
|
http://loinc.org | Demonstrates knowledge of medication management |
|
100007-4
|
http://loinc.org | Demonstrates knowledge of pain management |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
Demonstrates
knowledge
of
|
|
|
http://loinc.org |
|
|
100010-8
|
http://loinc.org | No injury related to procedure equipment, medical supplies, or instrumentation |
|
100011-6
|
http://loinc.org | No injury related to an electrical source |
|
100012-4
|
http://loinc.org | Participates in decisions affecting the patient's plan of care |
|
100013-2
|
http://loinc.org | Participates in the discharge process |
|
100014-0
|
http://loinc.org | Psychosocial health is maintained at or improved from baseline |
|
100015-7
|
http://loinc.org | No injury related to positioning due to care or procedure |
|
10001-6
|
http://loinc.org | R wave duration in lead I |
|
100016-5
|
http://loinc.org | No injury related to a laser source |
|
100017-3
|
http://loinc.org | Perioperative nursing data set outcomes panel [PNDS] |
|
100018-1
|
http://loinc.org | Hospice care Note |
|
100019-9
|
http://loinc.org | ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100020-7
|
http://loinc.org | GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100021-5
|
http://loinc.org | GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100022-3
|
http://loinc.org | IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100023-1
|
http://loinc.org | IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
10002-4
| http://loinc.org | R wave duration in lead II |
|
100024-9
|
http://loinc.org | SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100025-6
|
http://loinc.org | SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100026-4
|
http://loinc.org | MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100027-2
|
http://loinc.org | SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100028-0
|
http://loinc.org | FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
100029-8
|
http://loinc.org | Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
Axis
|
|
|
http://loinc.org |
|
|
100032-2
|
http://loinc.org | Axis III: Drug taking behavior score [Mainz Pain Staging System] |
|
100033-0
|
http://loinc.org | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] |
|
100034-8
|
http://loinc.org | Provider of automated external defibrillator use |
|
100035-5
|
http://loinc.org | Exam finding location of Chest |
|
100036-3
|
http://loinc.org | Exam finding location of Lung |
|
100037-1
|
http://loinc.org | Patient contact disposition EMS unit |
|
100038-9
|
http://loinc.org | Patient evaluation disposition EMS unit |
|
100039-7
|
http://loinc.org | Crew disposition for patient care EMS unit |
|
10004-0
|
http://loinc.org | R wave duration in lead V1 |
|
100040-5
|
http://loinc.org | Patient transport disposition EMS unit |
|
100041-3
|
http://loinc.org | Aminoglycoside [Susceptibility] |
|
100042-1
|
http://loinc.org | Atovaquone [Susceptibility] |
|
100043-9
|
http://loinc.org | Azithromycin+Ethambutol [Susceptibility] |
|
100044-7
|
http://loinc.org | Cefcapene [Susceptibility] |
|
100045-4
|
http://loinc.org | Cefozopran [Susceptibility] |
|
100046-2
|
http://loinc.org | Cefquinome [Susceptibility] |
|
100047-0
|
http://loinc.org | Cefteram [Susceptibility] |
|
100048-8
|
http://loinc.org | Clarithromycin+Ethambutol [Susceptibility] |
|
100049-6
|
http://loinc.org | Eravacycline [Susceptibility] |
|
|
http://loinc.org | Erythromycin+Ethambutol [Susceptibility] |
|
100051-2
|
http://loinc.org | Ethambutol+rifAMPin [Susceptibility] |
|
100052-0
|
http://loinc.org | Flomoxef [Susceptibility] |
|
100053-8
|
http://loinc.org | Fluoroquinolone [Susceptibility] |
|
100054-6
|
http://loinc.org | Gamithromycin [Susceptibility] |
|
100055-3
|
http://loinc.org | Optochin [Susceptibility] |
|
100056-1
|
http://loinc.org | Panipenem [Susceptibility] |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100060-3
|
http://loinc.org | Tildipirosin [Susceptibility] |
|
100061-1
|
http://loinc.org | Tosufloxacin [Susceptibility] |
|
100062-9
|
http://loinc.org | Standard Dermatology Outcome Measures panel |
|
100063-7
|
http://loinc.org | Primary skin concern |
|
100064-5
|
http://loinc.org | Itch severity Reporting Period - Reported |
|
10006-5
|
http://loinc.org | R wave duration in lead V3 |
|
100065-2
|
http://loinc.org | Satisfied with treatment |
|
100066-0
|
http://loinc.org | Specular microscopy panel |
|
100067-8
|
http://loinc.org | Eye Image magnification |
|
100068-6
|
http://loinc.org | Right eye Fixation point [Angle] |
|
100069-4
|
http://loinc.org | Left eye Fixation point [Angle] |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100073-6
|
http://loinc.org | Left cornea Coefficient of variation |
|
100074-4
|
http://loinc.org | Right cornea Hexagonality |
|
100075-1
|
http://loinc.org | Left cornea Hexagonality |
|
100076-9
|
http://loinc.org | Right cornea Endothelial cells counted |
|
100077-7
|
http://loinc.org | Left cornea Endothelial cells counted |
|
100078-5
|
http://loinc.org | Right cornea Endothelial cell area.min |
|
100079-3
|
http://loinc.org | Left cornea Endothelial cell area.min |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100081-9
|
http://loinc.org | Left cornea Endothelial cell area.max |
|
100082-7
|
http://loinc.org | Right cornea Endothelial cell area.mean |
|
100083-5
|
http://loinc.org | Left cornea Endothelial cell area.mean |
|
100084-3
|
http://loinc.org | Right cornea Cell area.standard deviation |
|
100085-0
|
http://loinc.org | Left cornea Cell area.standard deviation |
|
100086-8
|
http://loinc.org | Right cornea Type of Analysis method by Specular microscopy |
|
100087-6
|
http://loinc.org | Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot |
|
100088-4
|
http://loinc.org | Taenia solium larva Ab bands panel - Serum by Immunoblot |
|
100089-2
|
http://loinc.org | Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot |
|
|
http://loinc.org |
|
|
100090-0
|
http://loinc.org | Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot |
|
100091-8
|
http://loinc.org | Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay |
|
100092-6
|
http://loinc.org | Trypanosoma cruzi Ab bands panel - Serum by Immunoblot |
|
100093-4
|
http://loinc.org | Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot |
|
100094-2
|
http://loinc.org | Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot |
|
100095-9
|
http://loinc.org | Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
|
100096-7
|
http://loinc.org | Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot |
|
100097-5
|
http://loinc.org | Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot |
|
100098-3
|
http://loinc.org | Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100100-7
|
http://loinc.org | Fasciola sp IgG Ab [Presence] in Serum by Immunoassay |
|
100101-5
|
http://loinc.org | Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot |
|
100102-3
|
http://loinc.org | Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot |
|
100103-1
|
http://loinc.org | Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot |
|
100104-9
|
http://loinc.org | Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot |
|
100105-6
|
http://loinc.org | Filaria IgG and IgM panel - Serum |
|
100106-4
|
http://loinc.org | Filaria IgG Ab [Presence] in Serum by Immunoassay |
|
10010-7
| http://loinc.org | R' wave amplitude in lead AVF |
|
100107-2
|
http://loinc.org | Leishmania sp IgG Ab [Presence] in Serum by Immunoassay |
|
100108-0
|
http://loinc.org | Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay |
|
100109-8
|
http://loinc.org | Leishmania sp Ab bands panel - Serum by Immunoblot |
|
100110-6
|
http://loinc.org | Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot |
|
100111-4
|
http://loinc.org | Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot |
|
100112-2
|
http://loinc.org | Fasciola sp Ab bands panel - Serum by Immunoblot |
|
100113-0
|
http://loinc.org | Helicobacter pylori Ab panel - Serum |
|
100114-8
|
http://loinc.org | Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot |
|
10011-5
| http://loinc.org | R' wave amplitude in lead AVL |
|
100115-5
|
http://loinc.org | Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot |
|
100116-3
|
http://loinc.org | Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot |
|
100117-1
|
http://loinc.org | Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot |
|
100118-9
|
http://loinc.org | Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot |
|
100119-7
|
http://loinc.org | Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot |
|
100120-5
|
http://loinc.org | Chlamydia trachomatis Ab panel - Serum |
|
100121-3
|
http://loinc.org | Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay |
|
100122-1
|
http://loinc.org | Chlamydophila pneumoniae Ab panel - Serum |
|
10012-3
| http://loinc.org | R' wave amplitude in lead AVR |
|
100123-9
|
http://loinc.org | Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay |
|
100124-7
|
http://loinc.org | Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay |
|
100125-4
|
http://loinc.org | Chlamydophila psittaci Ab panel - Serum |
|
100126-2
|
http://loinc.org | Bordetella pertussis Ab.IgG panel - Serum |
|
100127-0
|
http://loinc.org | Campylobacter sp Ab panel - Serum |
|
100128-8
|
http://loinc.org | Cryptococcus sp Ag panel - Serum |
|
100129-6
|
http://loinc.org | Schistosoma sp Ab [Titer] in Serum by Hemagglutination |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100131-2
|
http://loinc.org | Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot |
|
100132-0
|
http://loinc.org | Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot |
|
100133-8
|
http://loinc.org | Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot |
|
100134-6
|
http://loinc.org | Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot |
|
100135-3
|
http://loinc.org | Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot |
|
100136-1
|
http://loinc.org | Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot |
|
100137-9
|
http://loinc.org | Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot |
|
100138-7
|
http://loinc.org | Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot |
|
100139-5
|
http://loinc.org | Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot |
|
100140-3
|
http://loinc.org | Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot |
|
100141-1
|
http://loinc.org | Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot |
|
100142-9
|
http://loinc.org | Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot |
|
100143-7
|
http://loinc.org | Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot |
|
100144-5
|
http://loinc.org | Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot |
|
100145-2
|
http://loinc.org | Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot |
|
100146-0
|
http://loinc.org | Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot |
|
100147-8
|
http://loinc.org | Toxoplasma gondii Ab bands panel - Serum by Immunoblot |
|
100148-6
|
http://loinc.org | Schistosoma sp Ab bands panel - Serum by Immunoblot |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100150-2
|
http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma |
|
100151-0
|
http://loinc.org | 6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma |
|
100152-8
|
http://loinc.org | 6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
|
100153-6
|
http://loinc.org | 6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine |
|
100154-4
|
http://loinc.org | Specimen collection supervision level |
|
100155-1
|
http://loinc.org | Left cornea Type of Analysis method by Specular microscopy |
|
10015-6
| http://loinc.org | R' wave amplitude in lead III |
|
100156-9
|
http://loinc.org | SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection |
|
100157-7
|
http://loinc.org | SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing |
|
100158-5
|
http://loinc.org | Microalbumin [Mass/volume] in Urine collected for unspecified duration |
|
100159-3
|
http://loinc.org | Knee Society Score pre-op panel [Knee Society Score] |
|
100160-1
|
http://loinc.org | Knee replacement |
|
100161-9
|
http://loinc.org | Charnley Functional Classification |
|
100162-7
|
http://loinc.org | Knee alignment W standing X-ray measured |
|
100163-5
|
http://loinc.org | Knee medial AndOr lateral instability W full extension |
|
10016-4
| http://loinc.org | R' wave amplitude in lead V1 |
|
100164-3
|
http://loinc.org | Knee AP instability W 90 degree flexion |
|
100165-0
|
http://loinc.org | Knee range of motion |
|
100166-8
|
http://loinc.org | Flexion contracture range of Knee |
|
100167-6
|
http://loinc.org | Extensor lag range of Knee |
|
100168-4
|
http://loinc.org | Knee pain severity with level walking |
|
100169-2
|
http://loinc.org | Knee pain severity with stairs or inclines |
|
|
http://loinc.org |
|
|
100170-0
|
http://loinc.org | Knee feels normal |
|
100171-8
|
http://loinc.org | Satisfaction with level of knee pain while sitting |
|
10017-2
| http://loinc.org | R' wave amplitude in lead V2 |
|
100172-6
|
http://loinc.org | Satisfaction with level of knee pain while lying in bed |
|
100173-4
|
http://loinc.org | Satisfaction with knee function while getting out of bed |
|
100174-2
|
http://loinc.org | Satisfaction with knee function while performing light household duties |
|
100175-9
|
http://loinc.org | Satisfaction with knee function while performing recreational activities |
|
100176-7
|
http://loinc.org | Expect surgery to relieve pain |
|
100177-5
|
http://loinc.org | Expect surgery will improve ability to perform activities of daily living |
|
100178-3
|
http://loinc.org | Expect surgery will improve ability to perform leisure, recreational, or sports activities |
|
100179-1
|
http://loinc.org | Walk without assistive mobility devices |
|
10018-0
|
http://loinc.org | R' wave amplitude in lead V3 |
|
100180-9
|
http://loinc.org | Assistive mobility devices used |
|
100181-7
|
http://loinc.org | Assistive mobility devices used due to health condition |
|
100182-5
|
http://loinc.org | Duration of standing before sitting due to knee discomfort |
|
100183-3
|
http://loinc.org | Duration of walking before stopping due to knee discomfort |
|
100184-1
|
http://loinc.org | How bothersome is knee when walking on an uneven surface |
|
100185-8
|
http://loinc.org | How bothersome is knee when turning or pivoting leg |
|
100186-6
|
http://loinc.org | How bothersome is knee when climbing up or down a flight of stairs |
|
100187-4
|
http://loinc.org | How bothersome is knee when getting up from a low seat without armrests |
|
100188-2
|
http://loinc.org | How bothersome is knee when getting into or out of a car |
|
100189-0
|
http://loinc.org | How bothersome is knee when moving laterally |
|
|
http://loinc.org | How bothersome is knee when climbing a ladder or step stool |
|
100191-6
|
http://loinc.org | How bothersome is knee when carrying a bag for one block |
|
100192-4
|
http://loinc.org | How bothersome is knee when squatting |
|
100193-2
|
http://loinc.org | How bothersome is knee when kneeling |
|
100194-0
|
http://loinc.org | How bothersome is knee when running |
|
100195-7
|
http://loinc.org | Pain severity--during activity |
|
100196-5
|
http://loinc.org | Pre-op total score [Knee Society Score] |
|
100197-3
|
http://loinc.org | Exercise activity and pain severity panel |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
Pre-op
|
|
|
http://loinc.org |
|
|
100200-5
|
http://loinc.org | Pre-op patient expectations score [Knee Society Score] |
|
100201-3
|
http://loinc.org | Pre-op functional activities score [Knee Society Score] |
|
100202-1
|
http://loinc.org | Pre-op discretionary knee activities score [Knee Society Score] |
|
100203-9
|
http://loinc.org | Knee Society Score post-op panel [Knee Society Score] |
|
100204-7
|
http://loinc.org | Accuracy of pre-surgery expectations of pain relief |
|
100205-4
|
http://loinc.org | Accuracy of pre-surgery expectations to perform activities of daily living |
|
10020-6
| http://loinc.org | R' wave amplitude in lead V5 |
|
100206-2
|
http://loinc.org | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities |
|
100207-0
|
http://loinc.org | Post-op total score [Knee Society Score] |
|
100208-8
|
http://loinc.org | Post-op objective knee indicators score [Knee Society Score] |
|
100209-6
|
http://loinc.org | Post-op symptoms score [Knee Society Score] |
|
100210-4
|
http://loinc.org | Post-op patient expectations score [Knee Society Score] |
|
100211-2
|
http://loinc.org | Post-op functional activities score [Knee Society Score] |
|
100212-0
|
http://loinc.org | Post-op discretionary knee activities score [Knee Society Score] |
|
100213-8
|
http://loinc.org | Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method |
|
10021-4
| http://loinc.org | R' wave amplitude in lead V6 |
|
100214-6
|
http://loinc.org | Dental model prior authorization Document |
|
100215-3
|
http://loinc.org | Episode of care medical records Document Transplant surgery |
|
100216-1
|
http://loinc.org | Surgical synoptic report |
|
100217-9
|
http://loinc.org |
Synoptic
report
Narrative
Surgical
oncology
|
|
100218-7
|
http://loinc.org | Surgical oncology of colon cancer synoptic report |
|
100219-5
|
http://loinc.org | Surgical oncology of melanoma cancer synoptic report |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
Surgical
oncology
of
|
|
|
http://loinc.org |
|
|
100222-9
|
http://loinc.org | Surgical oncology of pancreas cancer synoptic report |
|
100223-7
|
http://loinc.org | Physical findings of Retina Narrative |
|
100224-5
|
http://loinc.org | Cardiac left ventricular segmental wall motion by echo panel |
|
100225-2
|
http://loinc.org | Bone density quantitative ultrasound study |
|
100226-0
|
http://loinc.org | Small bowel capsule endoscopy study Document |
|
100227-8
|
http://loinc.org | Colon capsule endoscopy study Document |
|
100228-6
|
http://loinc.org | Upper gastrointestinal capsule endoscopy study Document |
|
100229-4
|
http://loinc.org | Endoscopic ultrasound study Document |
|
10023-0
|
http://loinc.org | R' wave duration in lead AVL |
|
100230-2
|
http://loinc.org | Routine prenatal assessment panel |
|
100231-0
|
http://loinc.org | Endobronchial ultrasound study |
|
100232-8
|
http://loinc.org | Impacts of Events Scale-Revised panel |
|
100233-6
|
http://loinc.org | Reminders brought back feelings about adverse event |
|
100234-4
|
http://loinc.org | Trouble staying asleep |
|
100235-1
|
http://loinc.org | Other things triggered persistent thoughts about adverse event |
|
100236-9
|
http://loinc.org | Felt irritable AndOr angry |
|
100237-7
|
http://loinc.org | Avoided getting upset when unintentionally thought about adverse event |
|
100238-5
|
http://loinc.org | Thought about adverse event unintentionally |
|
100239-3
|
http://loinc.org | Felt as if adverse event did not happen |
|
100240-1
|
http://loinc.org | Avoided reminders of adverse event |
|
100241-9
|
http://loinc.org | Experienced mental images of adverse event |
|
100242-7
|
http://loinc.org | Easily startled |
|
100243-5
|
http://loinc.org | Tried to not think of adverse event |
|
100244-3
|
http://loinc.org | Aware of feelings about adverse event, but did not address them |
|
100245-0
|
http://loinc.org | Feelings about adverse event were numb |
|
100246-8
|
http://loinc.org | Acted or felt the same as during adverse event |
|
100247-6
|
http://loinc.org | Trouble falling asleep |
|
10024-8
| http://loinc.org | R' wave duration in lead AVR |
|
100248-4
|
http://loinc.org | Waves of strong feelings about adverse event |
|
100249-2
|
http://loinc.org | Tried to remove adverse event from memory |
|
|
http://loinc.org |
|
|
100250-0
|
http://loinc.org | Trouble concentrating |
|
100251-8
|
http://loinc.org | Reminders of adverse event caused physical reactions |
|
100252-6
|
http://loinc.org | Had dreams about adverse event |
|
100253-4
|
http://loinc.org | Felt watchful and on-guard |
|
100254-2
|
http://loinc.org | Tried not to talk about adverse event |
|
10025-5
|
http://loinc.org | R' wave duration in lead I |
|
100255-9
|
http://loinc.org | Total score [Impact of Event Scale-Revised] |
|
100256-7
|
http://loinc.org | Fallen in last 6 months |
|
100257-5
|
http://loinc.org | Feel unsteady when standing or walking |
|
100258-3
|
http://loinc.org | History of fall related injury |
|
100259-1
|
http://loinc.org | Aware of tactile sensations |
|
|
http://loinc.org | Easy to describe thoughts AndOr feelings |
|
100261-7
|
http://loinc.org | Critical of own thoughts AndOr feelings |
|
100262-5
|
http://loinc.org | Able to notice distressing thoughts AndOr feelings without having to react |
|
10026-3
|
http://loinc.org | R' wave duration in lead II |
|
100263-3
|
http://loinc.org | Easily distracted |
|
100264-1
|
http://loinc.org | Able to notice thoughts AndOr feelings without being overwhelmed |
|
100265-8
|
http://loinc.org | Aware of dietary intake impact on self |
|
100266-6
|
http://loinc.org | Difficult to describe thoughts AndOr feelings |
|
100267-4
|
http://loinc.org | Aware of auditory stimuli |
|
100268-2
|
http://loinc.org | Able to avoid immediate reaction in difficult situations |
|
100269-0
|
http://loinc.org | Do things without paying attention |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100271-6
|
http://loinc.org | Aware of olfactory stimuli |
|
100272-4
|
http://loinc.org | Aware of visual stimuli |
|
100273-2
|
http://loinc.org | Aware of emotions affect on thoughts AndOr behavior |
|
100274-0
|
http://loinc.org | Observing score [FFMQ] |
|
100275-7
|
http://loinc.org | Describing score [FFMQ] |
|
100276-5
|
http://loinc.org | Acting with awareness score [FFMQ] |
|
100277-3
|
http://loinc.org | Nonjudging score [FFMQ] |
|
100278-1
|
http://loinc.org | Nonreactivity score [FFMQ] |
|
100279-9
|
http://loinc.org | Total score [FFMQ] |
|
100280-7
|
http://loinc.org | Five Facet Mindfulness Questionnaire panel [FFMQ] |
|
100281-5
|
http://loinc.org | D Ab [Units/volume] in Serum or Plasma |
|
100282-3
|
http://loinc.org | Vaccine exemption certificate |
|
100283-1
|
http://loinc.org | Harris Hip Score panel [Harris Hip Score] |
|
100284-9
|
http://loinc.org | Walking - functional ability |
|
100285-6
|
http://loinc.org | Comfortable seated position |
|
100286-4
|
http://loinc.org | Able to board public transportation |
|
100287-2
|
http://loinc.org | Put on shoes and socks |
|
100288-0
|
http://loinc.org | Absence of deformity score [Harris Hip Score] |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100290-6
|
http://loinc.org | Range of motion score [Harris Hip Score] |
|
100291-4
|
http://loinc.org | Total score [Harris Hip Score] |
|
100292-2
|
http://loinc.org | Pre-op patient satisfaction score [Knee Society Score] |
|
100293-0
|
http://loinc.org | Hip Flexion range of motion |
|
100294-8
|
http://loinc.org | Hip Abduction range of motion |
|
100295-5
|
http://loinc.org | Hip Adduction range of motion |
|
100296-3
|
http://loinc.org | Hip External rotation range of motion |
|
10029-7
| http://loinc.org | R' wave duration in lead V2 |
|
100297-1
|
http://loinc.org | Hip Internal rotation range of motion |
|
100298-9
|
http://loinc.org | Repetition count |
|
100299-7
|
http://loinc.org | Post-op patient satisfaction score [Knee Society Score] |
|
|
http://loinc.org | End time Unspecified body region |
|
100301-1
|
http://loinc.org | Start time Unspecified body region |
|
100302-9
|
http://loinc.org | Time period start and end panel Unspecified body region |
|
100303-7
|
http://loinc.org | Condition certainty of presence |
|
100304-5
|
http://loinc.org | Flights climbed [#] Reporting Period |
|
10030-5
| http://loinc.org | R' wave duration in lead V3 |
|
100305-2
|
http://loinc.org | IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
|
100306-0
|
http://loinc.org | IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method |
|
100307-8
|
http://loinc.org | Behavioral screening elder mistreatment |
|
100308-6
|
http://loinc.org | Need help getting to essential places |
|
100309-4
|
http://loinc.org | Activity support person |
|
100310-2
|
http://loinc.org | Reliability of support person |
|
100311-0
|
http://loinc.org | Need help to make sure there is enough food, medicines or any other things needed in house |
|
100312-8
|
http://loinc.org | Person or persons that makes sure there is enough food, medicines or any other things needed in house |
|
10031-3
| http://loinc.org | R' wave duration in lead V4 |
|
100313-6
|
http://loinc.org | Need help with household things such as cook meals, help feed, or provide correct medicines each day |
|
100314-4
|
http://loinc.org | Need help with house cleaning or yard work |
|
100315-1
|
http://loinc.org | Need help getting out of bed, showered, or dressed |
|
100316-9
|
http://loinc.org | Need help to make sure bills get paid |
|
100317-7
|
http://loinc.org | Relationship of usual support person for daily activities |
|
100318-5
|
http://loinc.org | Have help with finances AndOr financial decisions |
|
100319-3
|
http://loinc.org | Relationship of financial support person |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100321-9
|
http://loinc.org | Financial support person usually makes good decisions about finances |
|
100322-7
|
http://loinc.org | Have access to paperwork for financial decisions made |
|
100323-5
|
http://loinc.org | Financial support person forged signature |
|
100324-3
|
http://loinc.org | Coercion of financial support person for signing a document in order to get money or possessions |
|
100325-0
|
http://loinc.org | Experienced theft by support person |
|
100326-8
|
http://loinc.org | Money spent or property sold without permission |
|
100327-6
|
http://loinc.org | Stranger forged signature for financial gain |
|
100328-4
|
http://loinc.org | Stranger forced document signature for financial gain |
|
100329-2
|
http://loinc.org | Feared for safety due to verbal attack |
|
|
http://loinc.org |
|
|
100330-0
|
http://loinc.org | Felt humiliated due to ridicule |
|
100331-8
|
http://loinc.org | Coerced to do something |
|
100332-6
|
http://loinc.org | Ignored by close friend or relative for extended period |
|
100333-4
|
http://loinc.org | Physically hit or threatened |
|
100334-2
|
http://loinc.org | Been physically hurt with some degree of injury |
|
100335-9
|
http://loinc.org | Coerced sexual activity |
|
100336-7
|
http://loinc.org | Coerced touching of private body parts of self or others |
|
100337-5
|
http://loinc.org | Coerced to undress or expose private body area |
|
100338-3
|
http://loinc.org | Photographed in any degree of nudity without consent |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100340-9
|
http://loinc.org | Range of motion panel Hip |
|
100341-7
|
http://loinc.org | Rubella virus IgG Ab index [Units/volume] in Serum and CSF |
|
100342-5
|
http://loinc.org | Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry |
|
100343-3
|
http://loinc.org | Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
|
100344-1
|
http://loinc.org | Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection |
|
100345-8
|
http://loinc.org | Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
|
100346-6
|
http://loinc.org | Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG |
|
10034-7
| http://loinc.org | S wave amplitude in lead AVF |
|
100347-4
|
http://loinc.org | Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG |
|
100348-2
|
http://loinc.org | Model for end-stage liver disease sodium score |
|
100349-0
|
http://loinc.org | US.doppler Penis vessels W vasodilator IV |
|
100350-8
|
http://loinc.org | Sesamum indicum 1 IgE Ab [Units/volume] in Serum |
|
100351-6
|
http://loinc.org | Pioglitazone [Presence] in Serum or Plasma |
|
100352-4
|
http://loinc.org | Rosiglitazone [Presence] in Serum or Plasma |
|
100353-2
|
http://loinc.org | Norwalk Community Health Center Screening Tool [NCHC] |
|
10035-4
| http://loinc.org | S wave amplitude in lead AVL |
|
100354-0
|
http://loinc.org | Frequency of participating in multi-modal communication without assistance |
|
100355-7
|
http://loinc.org | Frequency of participating in spoken language expression communication without assistance |
|
100356-5
|
http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection |
|
100357-3
|
http://loinc.org | Naloxone [Presence] in Cord tissue by Screen method |
|
100358-1
|
http://loinc.org | Phentermine [Presence] in Cord tissue by Screen method |
|
100359-9
|
http://loinc.org | Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100362-3
|
http://loinc.org | Difficulty making it through stressful events |
|
100363-1
|
http://loinc.org | Easily recover from a stressful event |
|
100364-9
|
http://loinc.org | Difficulty recovering from bad events |
|
100365-6
|
http://loinc.org | Easily recover from difficulties |
|
100366-4
|
http://loinc.org | Lengthy recovery from setbacks |
|
100367-2
|
http://loinc.org | Total Score BRS |
|
100368-0
|
http://loinc.org | Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS |
|
100369-8
|
http://loinc.org | NM Thyroid gland Views W Tl-201 IV |
|
10037-0
|
http://loinc.org | S wave amplitude in lead I |
|
100370-6
|
http://loinc.org | Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection |
|
100371-4
|
http://loinc.org | Titin Ab [Units/volume] in Serum by Immunoassay |
|
100372-2
|
http://loinc.org | Abiraterone [Mass/volume] in Serum or Plasma |
|
100373-0
|
http://loinc.org | Eucheuma IgG Ab [Units/volume] in Serum |
|
100374-8
|
http://loinc.org | Aloe vera IgG Ab [Units/volume] in Serum |
|
100375-5
|
http://loinc.org | Anise IgG Ab [Units/volume] in Serum |
|
100376-3
|
http://loinc.org | Bambusa vulgaris IgG Ab [Units/volume] in Serum |
|
100377-1
|
http://loinc.org | Goat cheese IgG Ab [Units/volume] in Serum |
|
100378-9
|
http://loinc.org | Sheep cheese IgG Ab [Units/volume] in Serum |
|
100379-7
|
http://loinc.org | Leeks IgG Ab [Units/volume] in Serum |
|
100380-5
|
http://loinc.org | Red cabbage IgG Ab [Units/volume] in Serum |
|
100381-3
|
http://loinc.org | Mentha balsamea Wild IgG Ab [Units/volume] in Serum |
|
100382-1
|
http://loinc.org | FDA package insert REMS addressed risk |
|
100383-9
|
http://loinc.org | Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection |
|
100384-7
|
http://loinc.org | Rapeseed IgG Ab [Units/volume] in Serum |
|
100385-4
|
http://loinc.org | Corn salad IgG Ab [Units/volume] in Serum |
|
100386-2
|
http://loinc.org | Rosemary IgG Ab [Units/volume] in Serum |
|
100387-0
|
http://loinc.org | Poppy Seed IgG Ab [Units/volume] in Serum |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100390-4
|
http://loinc.org | Sunflower Seed IgG Ab [Units/volume] in Serum |
|
100391-2
|
http://loinc.org | Dates IgG Ab [Units/volume] in Serum |
|
100392-0
|
http://loinc.org | Duck meat IgG Ab [Units/volume] in Serum |
|
100393-8
|
http://loinc.org | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum |
|
100394-6
|
http://loinc.org | Astacoidea IgG Ab [Units/volume] in Serum |
|
100395-3
|
http://loinc.org | Carob IgG Ab [Units/volume] in Serum |
|
10039-6
| http://loinc.org | S wave amplitude in lead III |
|
100396-1
|
http://loinc.org | Brassica napus IgG Ab [Units/volume] in Serum |
|
100397-9
|
http://loinc.org | Goat Meat IgG Ab [Units/volume] in Serum |
|
100398-7
|
http://loinc.org | Goose meat IgG Ab [Units/volume] in Serum |
|
100399-5
|
http://loinc.org | Ostrich meat IgG Ab [Units/volume] in Serum |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100404-3
|
http://loinc.org | Horse meat IgG Ab [Units/volume] in Serum |
|
100405-0
|
http://loinc.org | Kefir IgG Ab [Units/volume] in Serum |
|
100406-8
|
http://loinc.org | Butter IgG Ab [Units/volume] in Serum |
|
100407-6
|
http://loinc.org | Camembert cheese IgG Ab [Units/volume] in Serum |
|
100408-4
|
http://loinc.org | Emmental cheese IgG Ab [Units/volume] in Serum |
|
100409-2
|
http://loinc.org | Processed cheese IgG Ab [Units/volume] in Serum |
|
|
http://loinc.org |
|
|
100410-0
|
http://loinc.org | Curd cheese IgG Ab [Units/volume] in Serum |
|
100411-8
|
http://loinc.org | Sugar Beet IgG Ab [Units/volume] in Serum |
|
10041-2
| http://loinc.org | S wave amplitude in lead V2 |
|
100412-6
|
http://loinc.org | Chinese cabbage IgG Ab [Units/volume] in Serum |
|
100413-4
|
http://loinc.org | Fennel Fresh IgG Ab [Units/volume] in Serum |
|
100414-2
|
http://loinc.org | Gourd IgG Ab [Units/volume] in Serum |
|
100415-9
|
http://loinc.org | Kale IgG Ab [Units/volume] in Serum |
|
100416-7
|
http://loinc.org | Savoy cabbage IgG Ab [Units/volume] in Serum |
|
100417-5
|
http://loinc.org | Vitis sp leaf IgG Ab [Units/volume] in Serum |
|
100418-3
|
http://loinc.org | Liquorice IgG Ab [Units/volume] in Serum |
|
100419-1
|
http://loinc.org | Snow pea IgG Ab [Units/volume] in Serum |
|
10042-0
|
http://loinc.org | S wave amplitude in lead V3 |
|
100420-9
|
http://loinc.org | Fava bean IgG Ab [Units/volume] in Serum |
|
100421-7
|
http://loinc.org | Chick Pea IgG Ab [Units/volume] in Serum |
|
100422-5
|
http://loinc.org | Chicory IgG Ab [Units/volume] in Serum |
|
100423-3
|
http://loinc.org | Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum |
|
100424-1
|
http://loinc.org | 8(9)-Cholestenol [Mass/volume] in Serum or Plasma |
|
100425-8
|
http://loinc.org | DiHydro T-Mas [Mass/volume] in Serum or Plasma |
|
100426-6
|
http://loinc.org | Squalene [Mass/volume] in Serum or Plasma |
|
100427-4
|
http://loinc.org | Stigmasterol [Mass/volume] in Serum or Plasma |
|
100428-2
|
http://loinc.org | Carnitine free and total and acylcarnitine panel - Urine |
|
100429-0
|
http://loinc.org | LRBA deficiency panel - Blood |
|
|
http://loinc.org |
|
|
100431-6
|
http://loinc.org | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
|
100432-4
|
http://loinc.org |
|
|
100433-2
|
http://loinc.org | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC) |
|
100434-0
|
http://loinc.org | Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection |
|
100435-7
|
http://loinc.org | Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay |
|
100436-5
|
http://loinc.org | Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay |
|
100437-3
|
http://loinc.org | Norsufentanil [Mass/volume] in Urine by Confirmatory method |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100440-7
|
http://loinc.org | Allergy Outpatient Progress note |
|
100441-5
|
http://loinc.org | Attending Outpatient Progress note |
|
100442-3
|
http://loinc.org | Audiology Outpatient Progress note |
|
100443-1
|
http://loinc.org | Bariatric surgery Outpatient Progress note |
|
100444-9
|
http://loinc.org | Blood banking and transfusion medicine Outpatient Progress note |
|
100445-6
|
http://loinc.org | Bone Marrow Transplant Outpatient Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100450-6
|
http://loinc.org | Child and adolescent psychiatry Outpatient Progress note |
|
100451-4
|
http://loinc.org | Chiropractic medicine Outpatient Progress note |
|
100452-2
|
http://loinc.org | Clinical cardiac electrophysiology Outpatient Progress note |
|
10045-3
|
http://loinc.org | S wave amplitude in lead V6 |
|
100453-0
|
http://loinc.org | Clinical genetics Outpatient Progress note |
|
100454-8
|
http://loinc.org | Clinical neurophysiology Outpatient Progress note |
|
100455-5
|
http://loinc.org | Clinical pathology Outpatient Progress note |
|
100456-3
|
http://loinc.org | Colon and rectal surgery Outpatient Progress note |
|
100457-1
|
http://loinc.org | Consultant Outpatient Progress note |
|
100458-9
|
http://loinc.org | Outpatient COVID-19 Intubation Progress note |
|
100459-7
|
http://loinc.org | Outpatient COVID-19 Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100461-3
|
http://loinc.org | Developmental-behavioral pediatrics Outpatient Progress note |
|
100462-1
|
http://loinc.org | Dialysis and Therapeutic apheresis Outpatient Progress note |
|
100463-9
|
http://loinc.org | Eating disorders Outpatient Progress note |
|
100464-7
|
http://loinc.org | Endocrinology Outpatient Progress note |
|
100465-4
|
http://loinc.org | Family medicine Outpatient Progress note |
|
100466-2
|
http://loinc.org | Gastroenterology Outpatient Progress note |
|
100467-0
|
http://loinc.org | Geriatric medicine Outpatient Progress note |
|
100468-8
|
http://loinc.org | Gynecologic oncology Outpatient Progress note |
|
100469-6
|
http://loinc.org | Gynecology Outpatient Progress note |
|
|
http://loinc.org | Healthcare navigator Outpatient Progress note |
|
100471-2
|
http://loinc.org | Heart failure Outpatient Progress note |
|
100472-0
|
http://loinc.org | Heart failure+Transplant cardiology Outpatient Progress note |
|
100473-8
|
http://loinc.org | Hematology Outpatient Progress note |
|
100474-6
|
http://loinc.org | Hematology+Medical oncology Outpatient Progress note |
|
100475-3
|
http://loinc.org | Hepatology Outpatient Progress note |
|
100476-1
|
http://loinc.org | Immunology Outpatient Progress note |
|
100477-9
|
http://loinc.org | Infectious disease Outpatient Progress note |
|
100478-7
|
http://loinc.org | Internal medicine Outpatient Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100480-3
|
http://loinc.org | Interventional radiology Outpatient Progress note |
|
100481-1
|
http://loinc.org | Outpatient Mechanical circulatory support Progress note |
|
100482-9
|
http://loinc.org | Medical Aid in Dying Outpatient Progress note |
|
100483-7
|
http://loinc.org | Mental health Outpatient Progress note |
|
100484-5
|
http://loinc.org | Multi-specialty program Outpatient Progress note |
|
100485-2
|
http://loinc.org | Neonatal perinatal medicine Outpatient Progress note |
|
100486-0
|
http://loinc.org | Nephrology Outpatient Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
Neurology
|
|
|
http://loinc.org |
|
|
100490-2
|
http://loinc.org | Nurse practitioner Outpatient Progress note |
|
100491-0
|
http://loinc.org | Nurse Outpatient Progress note |
|
100492-8
|
http://loinc.org | Nutrition and dietetics Outpatient Progress note |
|
100493-6
|
http://loinc.org | Obstetrics and Gynecology Outpatient Progress note |
|
100494-4
|
http://loinc.org | Obstetrics Outpatient Progress note |
|
10049-5
| http://loinc.org | S wave duration in lead I |
|
100495-1
|
http://loinc.org | Occupational therapy Outpatient Progress note |
|
100496-9
|
http://loinc.org | Oncology Outpatient Progress note |
|
100497-7
|
http://loinc.org | Ophthalmology Outpatient Progress note |
|
100498-5
|
http://loinc.org | Optometry Outpatient Progress note |
|
100499-3
|
http://loinc.org | Oral and Maxillofacial Surgery Outpatient Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100503-2
|
http://loinc.org | Pain medicine Outpatient Progress note |
|
100504-0
|
http://loinc.org | Palliative care Outpatient Progress note |
|
100505-7
|
http://loinc.org | Pediatric cardiology Outpatient Progress note |
|
100506-5
|
http://loinc.org | Pediatric dermatology Outpatient Progress note |
|
100507-3
|
http://loinc.org | Pediatric endocrinology Outpatient Progress note |
|
100508-1
|
http://loinc.org | Pediatric gastroenterology Outpatient Progress note |
|
100509-9
|
http://loinc.org | Pediatric hematology-oncology Outpatient Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100511-5
|
http://loinc.org | Pediatric otolaryngology Outpatient Progress note |
|
100512-3
|
http://loinc.org | Pediatric pulmonology Outpatient Progress note |
|
100513-1
|
http://loinc.org | Pediatric rheumatology Outpatient Progress note |
|
100514-9
|
http://loinc.org | Pediatric surgery Outpatient Progress note |
|
100515-6
|
http://loinc.org | Pediatric transplant hepatology Outpatient Progress note |
|
100516-4
|
http://loinc.org | Pediatric urology Outpatient Progress note |
|
100517-2
|
http://loinc.org | Pharmacogenomics Outpatient Progress note |
|
100518-0
|
http://loinc.org | Physical medicine and rehab Outpatient Progress note |
|
100519-8
|
http://loinc.org | Physical therapy Outpatient Progress note |
|
|
http://loinc.org | Plastic surgery Outpatient Progress note |
|
100521-4
|
http://loinc.org | Podiatry Outpatient Progress note |
|
100522-2
|
http://loinc.org | Psychiatry Hospital Progress note |
|
100523-0
|
http://loinc.org | Psychology Outpatient Progress note |
|
100524-8
|
http://loinc.org | Pulmonary Outpatient Progress note |
|
100525-5
|
http://loinc.org | Radiation oncology Outpatient Progress note |
|
100526-3
|
http://loinc.org | Radiology Outpatient Progress note |
|
100527-1
|
http://loinc.org | Recreational therapy Outpatient Progress note |
|
100528-9
|
http://loinc.org | Reproductive endocrinology and infertility Outpatient Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100530-5
|
http://loinc.org | Rheumatology Outpatient Progress note |
|
100531-3
|
http://loinc.org | Sleep medicine Outpatient Progress note |
|
100532-1
|
http://loinc.org | Social worker Outpatient Progress note |
|
100533-9
|
http://loinc.org | Solid Organ Transplant Outpatient Progress note |
|
100534-7
|
http://loinc.org | Speech-language pathology Outpatient Progress note |
|
100535-4
|
http://loinc.org | Spinal surgery Outpatient Progress note |
|
100536-2
|
http://loinc.org | Sports medicine Outpatient Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100540-4
|
http://loinc.org | Transplant surgery Outpatient Progress note |
|
100541-2
|
http://loinc.org | Trauma Outpatient Progress note |
|
100542-0
|
http://loinc.org | Urology Outpatient Progress note |
|
100543-8
|
http://loinc.org | Vascular neurology Outpatient Progress note |
|
100544-6
|
http://loinc.org | Vascular surgery Outpatient Progress note |
|
10054-5
| http://loinc.org | S wave duration in lead V3 |
|
100545-3
|
http://loinc.org | Wound care management Outpatient Progress note |
|
100546-1
|
http://loinc.org | Wound, Ostomy, and Continence Care Outpatient Progress note |
|
100547-9
|
http://loinc.org | Adolescent medicine Hospital Progress note |
|
100548-7
|
http://loinc.org | Allergy and Immunology Hospital Progress note |
|
100549-5
|
http://loinc.org | Allergy Hospital Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100552-9
|
http://loinc.org | Bariatric surgery Hospital Progress note |
|
100553-7
|
http://loinc.org | Blood banking and transfusion medicine Hospital Progress note |
|
100554-5
|
http://loinc.org | Bone Marrow Transplant Hospital Progress note |
|
100555-2
|
http://loinc.org | Breastfeeding Hospital Progress note |
|
100556-0
|
http://loinc.org | Burn management Hospital Progress note |
|
100557-8
|
http://loinc.org | Cardiac surgery Hospital Progress note |
|
100558-6
|
http://loinc.org | Cardiopulmonary Hospital Progress note |
|
100559-4
|
http://loinc.org | Child and adolescent psychiatry Hospital Progress note |
|
10056-0
|
http://loinc.org | S wave duration in lead V5 |
|
100560-2
|
http://loinc.org | Clinical cardiac electrophysiology Hospital Progress note |
|
100561-0
|
http://loinc.org | Clinical genetics Hospital Progress note |
|
100562-8
|
http://loinc.org | Clinical neurophysiology Hospital Progress note |
|
100563-6
|
http://loinc.org | Clinical pathology Hospital Progress note |
|
100564-4
|
http://loinc.org | Colon and rectal surgery Hospital Progress note |
|
100565-1
|
http://loinc.org | Consultant Hospital Progress note |
|
100566-9
|
http://loinc.org | Dentistry Hospital Progress note |
|
100567-7
|
http://loinc.org | Dermatology Hospital Progress note |
|
100568-5
|
http://loinc.org | Developmental-behavioral pediatrics Hospital Progress note |
|
100569-3
|
http://loinc.org | Dialysis and Therapeutic apheresis Hospital Progress note |
|
100570-1
|
http://loinc.org | Eating disorders Hospital Progress note |
|
100571-9
|
http://loinc.org | Endocrinology Hospital Progress note |
|
100572-7
|
http://loinc.org | Family medicine Hospital Progress note |
|
100573-5
|
http://loinc.org | Gastroenterology Hospital Progress note |
|
100574-3
|
http://loinc.org | General medicine Hospital Progress note |
|
100575-0
|
http://loinc.org | Geriatric medicine Hospital Progress note |
|
100576-8
|
http://loinc.org | Gynecologic oncology Hospital Progress note |
|
100577-6
|
http://loinc.org | Gynecology Hospital Progress note |
|
10057-8
|
http://loinc.org | S wave duration in lead V6 |
|
100578-4
|
http://loinc.org | Healthcare navigator Hospital Progress note |
|
100579-2
|
http://loinc.org | Heart failure Hospital Progress note |
|
|
http://loinc.org |
|
|
100580-0
|
http://loinc.org | Heart failure+Transplant cardiology Hospital Progress note |
|
100581-8
|
http://loinc.org | Hematology Hospital Progress note |
|
100582-6
|
http://loinc.org | Hematology+Medical oncology Hospital Progress note |
|
100583-4
|
http://loinc.org | Hepatology Hospital Progress note |
|
100584-2
|
http://loinc.org | Immunology Hospital Progress note |
|
100585-9
|
http://loinc.org | Infectious disease Hospital Progress note |
|
10058-6
|
http://loinc.org | S' wave amplitude in lead AVF |
|
100586-7
|
http://loinc.org | Internal medicine Hospital Progress note |
|
100587-5
|
http://loinc.org | Interventional cardiology Hospital Progress note |
|
100588-3
|
http://loinc.org | Interventional radiology Hospital Progress note |
|
100589-1
|
http://loinc.org | Hospital Mechanical circulatory support Progress note |
|
100590-9
|
http://loinc.org | Medical Aid in Dying Hospital Progress note |
|
100591-7
|
http://loinc.org | Mental health Hospital Progress note |
|
100592-5
|
http://loinc.org | Multi-specialty program Hospital Progress note |
|
100593-3
|
http://loinc.org | Neonatal perinatal medicine Hospital Progress note |
|
10059-4
| http://loinc.org | S' wave amplitude in lead AVL |
|
100594-1
|
http://loinc.org | Nephrology Hospital Progress note |
|
100595-8
|
http://loinc.org | Neurological surgery Hospital Progress note |
|
100596-6
|
http://loinc.org | Neurology Hospital Progress note |
|
100597-4
|
http://loinc.org | Neurology with special qualifications in child neurology Hospital Progress note |
|
100598-2
|
http://loinc.org | Nurse practitioner Hospital Progress note |
|
100599-0
|
http://loinc.org | Nurse Hospital Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100602-2
|
http://loinc.org | Obstetrics Hospital Progress note |
|
100603-0
|
http://loinc.org | Occupational therapy Hospital Progress note |
|
100604-8
|
http://loinc.org | Oncology Hospital Progress note |
|
100605-5
|
http://loinc.org | Ophthalmology Hospital Progress note |
|
100606-3
|
http://loinc.org | Oral and Maxillofacial Surgery Hospital Progress note |
|
100607-1
|
http://loinc.org | Orthopaedic surgery Hospital Progress note |
|
100608-9
|
http://loinc.org | Orthotics prosthetics Hospital Progress note |
|
100609-7
|
http://loinc.org | Otolaryngology Hospital Progress note |
|
10061-0
|
http://loinc.org | S' wave amplitude in lead I |
|
100610-5
|
http://loinc.org | Pain medicine Hospital Progress note |
|
100611-3
|
http://loinc.org | Palliative care Hospital Progress note |
|
100612-1
|
http://loinc.org | Pastoral care Hospital Progress note |
|
100613-9
|
http://loinc.org | Pediatric cardiology Hospital Progress note |
|
100614-7
|
http://loinc.org | Pediatric dermatology Hospital Progress note |
|
100615-4
|
http://loinc.org | Pediatric endocrinology Hospital Progress note |
|
100616-2
|
http://loinc.org | Pediatric gastroenterology Hospital Progress note |
|
100617-0
|
http://loinc.org | Pediatric hematology-oncology Hospital Progress note |
|
100618-8
|
http://loinc.org | Pediatric infectious diseases Hospital Progress note |
|
100619-6
|
http://loinc.org | Pediatric otolaryngology Hospital Progress note |
|
|
http://loinc.org | Pediatric pulmonology Hospital Progress note |
|
100621-2
|
http://loinc.org | Pediatric rheumatology Hospital Progress note |
|
100622-0
|
http://loinc.org | Pediatric surgery Hospital Progress note |
|
100623-8
|
http://loinc.org | Pediatric transplant hepatology Hospital Progress note |
|
100624-6
|
http://loinc.org | Pharmacogenomics Hospital Progress note |
|
100625-3
|
http://loinc.org | Pharmacology Hospital Progress note |
|
100626-1
|
http://loinc.org | Physical medicine and rehab Hospital Progress note |
|
100627-9
|
http://loinc.org | Physical therapy Hospital Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100630-3
|
http://loinc.org | Psychology Hospital Progress note |
|
100631-1
|
http://loinc.org | Radiation oncology Hospital Progress note |
|
100632-9
|
http://loinc.org | Radiology Hospital Progress note |
|
100633-7
|
http://loinc.org | Rapid response team Hospital Progress note |
|
100634-5
|
http://loinc.org | Recreational therapy Hospital Progress note |
|
100635-2
|
http://loinc.org | Reproductive endocrinology and infertility Hospital Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100640-2
|
http://loinc.org | Solid Organ Transplant Hospital Progress note |
|
100641-0
|
http://loinc.org | Speech-language pathology Hospital Progress note |
|
100642-8
|
http://loinc.org | Spinal surgery Hospital Progress note |
|
100643-6
|
http://loinc.org | Surgery of the hand Hospital Progress note |
|
10064-4
| http://loinc.org | S' wave amplitude in lead V1 |
|
100644-4
|
http://loinc.org | Thromboembolism Hospital Progress note |
|
100645-1
|
http://loinc.org | Trauma Hospital Progress note |
|
100646-9
|
http://loinc.org | Urology Hospital Progress note |
|
100647-7
|
http://loinc.org | Vascular neurology Hospital Progress note |
|
100648-5
|
http://loinc.org | Vascular surgery Hospital Progress note |
|
100649-3
|
http://loinc.org | Wound care management Hospital Progress note |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100651-9
|
http://loinc.org | Hospital COVID-19 Intubation Progress note |
|
100652-7
|
http://loinc.org | Pure tone bone conduction threshold audiometry panel |
|
100653-5
|
http://loinc.org | Pure tone air conduction threshold audiometry panel |
|
100654-3
|
http://loinc.org | Pyruvate kinase M2 [Presence] in Stool |
|
100655-0
|
http://loinc.org | XR Sella turcica Lateral |
|
100656-8
|
http://loinc.org | Maternal and fetal medicine Outpatient Progress note |
|
100657-6
|
http://loinc.org | Maternal and fetal medicine Telephone encounter+Hospital Progress note |
|
100658-4
|
http://loinc.org | Hospital COVID-19 Progress note |
|
100659-2
|
http://loinc.org | Maternal and fetal medicine Hospital Progress note |
|
|
http://loinc.org |
|
|
100660-0
|
http://loinc.org | Maternal and fetal medicine Telephone encounter+Outpatient Progress note |
|
100661-8
|
http://loinc.org | Psychiatry Outpatient Progress note |
|
100662-6
|
http://loinc.org | Cortisol free and total panel - Serum or Plasma |
|
100663-4
|
http://loinc.org | TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |
|
100664-2
|
http://loinc.org | NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |
|
100665-9
|
http://loinc.org | NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |
|
100666-7
|
http://loinc.org | NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |
|
100667-5
|
http://loinc.org | NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |
|
100668-3
|
http://loinc.org | NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100670-9
|
http://loinc.org | RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |
|
100671-7
|
http://loinc.org | Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |
|
100672-5
|
http://loinc.org | Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection |
|
100673-3
|
http://loinc.org | Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection |
|
100674-1
|
http://loinc.org | BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
100675-8
|
http://loinc.org | Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection |
|
100676-6
|
http://loinc.org | Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection |
|
10067-7
| http://loinc.org | S' wave amplitude in lead V4 |
|
100677-4
|
http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
100678-2
|
http://loinc.org | Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
100679-0
|
http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
100680-8
|
http://loinc.org | Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
100681-6
|
http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
100682-4
|
http://loinc.org | Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
100683-2
|
http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
100684-0
|
http://loinc.org | Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
10068-5
|
http://loinc.org | S' wave amplitude in lead V5 |
|
100685-7
|
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection |
|
100686-5
|
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
100687-3
|
http://loinc.org | JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection |
|
100688-1
|
http://loinc.org | Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
100689-9
|
http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection |
|
|
http://loinc.org | Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection |
|
100691-5
|
http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection |
|
100692-3
|
http://loinc.org | Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection |
|
10069-3
| http://loinc.org | S' wave amplitude in lead V6 |
|
100693-1
|
http://loinc.org |
Pneumocystis
|
|
100694-9
|
http://loinc.org | SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method |
|
100695-6
|
http://loinc.org | Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative |
|
100696-4
|
http://loinc.org | CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal |
|
100697-2
|
http://loinc.org | Interventional radiology Outpatient Note |
|
100698-0
|
http://loinc.org | Social Determinants of Health screening report Document |
|
100699-8
|
http://loinc.org | Rifabutin+Ethambutol [Susceptibility] |
|
|
http://loinc.org |
|
|
10070-1
|
http://loinc.org | S' wave duration in lead AVF |
|
|
http://loinc.org | Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection |
|
100702-0
|
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection |
|
100703-8
|
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection |
|
100704-6
|
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection |
|
100705-3
|
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection |
|
100706-1
|
http://loinc.org | Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection |
|
100707-9
|
http://loinc.org |
|
|
100708-7
|
http://loinc.org |
Plasma
|
|
100709-5
|
http://loinc.org | Hepatocellular carcinoma risk [Score] by GAAD |
|
100710-3
|
http://loinc.org | Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection |
|
100711-1
|
http://loinc.org | Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay |
|
100712-9
|
http://loinc.org | Brexpiprazole [Mass/volume] in Serum or Plasma |
|
100713-7
|
http://loinc.org | Cariprazine [Mass/volume] in Serum or Plasma |
|
100714-5
|
http://loinc.org | Guanfacine [Mass/volume] in Serum or Plasma |
|
100715-2
|
http://loinc.org | Prothipendyl [Mass/volume] in Serum or Plasma |
|
100716-0
|
http://loinc.org | Prostate specific Ag [Mass/volume] in DBS |
|
100717-8
|
http://loinc.org | FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method |
|
100718-6
|
http://loinc.org | Undersea and hyperbaric medicine Discharge summary |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100720-2
|
http://loinc.org | Reproductive endocrinology and infertility Discharge summary |
|
100721-0
|
http://loinc.org | Community health care Discharge summary |
|
100722-8
|
http://loinc.org | Integrative medicine Discharge summary |
|
100723-6
|
http://loinc.org | Sports medicine Discharge summary |
|
100724-4
|
http://loinc.org | Diabetology Discharge summary |
|
100725-1
|
http://loinc.org | Optometry Discharge summary |
|
100726-9
|
http://loinc.org | Podiatry Discharge summary |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100730-1
|
http://loinc.org | Transplant surgery Discharge summary |
|
100731-9
|
http://loinc.org | Urgent care center Discharge summary |
|
100732-7
|
http://loinc.org | Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum |
|
100733-5
|
http://loinc.org | Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a) |
|
100734-3
|
http://loinc.org | traMADol and Metabolites Panel - Urine by Confirmatory method |
|
10073-5
| http://loinc.org | S' wave duration in lead I |
|
100735-0
|
http://loinc.org | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes |
|
100736-8
|
http://loinc.org | Acylcarnitine Analysis Post Mortem in Specimen Document |
|
100737-6
|
http://loinc.org | Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma |
|
100738-4
|
http://loinc.org | Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma |
|
100739-2
|
http://loinc.org | Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma |
|
|
http://loinc.org |
|
|
100740-0
|
http://loinc.org | Amylase.macromolecular [Presence] in Serum or Plasma |
|
100741-8
|
http://loinc.org | Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma |
|
100742-6
|
http://loinc.org | Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma |
|
10074-3
| http://loinc.org | S' wave duration in lead II |
|
100743-4
|
http://loinc.org | Lipase.macromolecular [Presence] in Serum or Plasma |
|
100744-2
|
http://loinc.org | Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis |
|
100745-9
|
http://loinc.org | Chloride [Moles/volume] in Mixed venous blood |
|
100746-7
|
http://loinc.org | Glucose [Moles/volume] in Mixed venous blood |
|
100747-5
|
http://loinc.org | Legionella serogroup panel - Specimen |
|
100748-3
|
http://loinc.org | Legionella spp [Presence] in Specimen by NAA with probe detection |
|
100749-1
|
http://loinc.org | Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection |
|
10075-0
|
http://loinc.org | S' wave duration in lead III |
|
100750-9
|
http://loinc.org | Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection |
|
100751-7
|
http://loinc.org | Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma |
|
100752-5
|
http://loinc.org | Exacerbating factors - Reported |
|
100753-3
|
http://loinc.org | Alleviating factors - Reported |
|
100754-1
|
http://loinc.org | Platelet disorders multigene analysis in Blood or Tissue by Sequencing |
|
100755-8
|
http://loinc.org | Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing |
|
100756-6
|
http://loinc.org | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing |
|
100757-4
|
http://loinc.org | Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing |
|
100758-2
|
http://loinc.org | Estimated lung age by based on clinical data |
|
100759-0
|
http://loinc.org | Inspiratory reserve [Volume] Respiratory system by Spirometry |
|
100760-8
|
http://loinc.org | XR Radius and Ulna - left Single view |
|
100761-6
|
http://loinc.org | PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
100762-4
|
http://loinc.org | HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method |
|
100763-2
|
http://loinc.org | Mycobacterium sp comparative reaction interpretation Narrative |
|
100764-0
|
http://loinc.org | Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal |
|
100765-7
|
http://loinc.org | Homocysteine and methylmalonate and methylcitrate panel - DBS |
|
100766-5
|
http://loinc.org | Center for Epidemiologic Studies Depression Scale panel [CES-D] |
|
100767-3
|
http://loinc.org | Bothered by things that are not usually bothersome |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100770-7
|
http://loinc.org | Feeling just as good as others |
|
100771-5
|
http://loinc.org | Trouble focusing |
|
100772-3
|
http://loinc.org | Feeling depressed |
|
100773-1
|
http://loinc.org | Feeling everything is too much of an effort |
|
100774-9
|
http://loinc.org | Feeling hopeful about the future |
|
100775-6
|
http://loinc.org | Feeling life had been a failure |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100780-6
|
http://loinc.org | Feeling lonely |
|
100781-4
|
http://loinc.org | People were unfriendly |
|
100782-2
|
http://loinc.org | Enjoying life |
|
100783-0
|
http://loinc.org | Crying spells |
|
10078-4
| http://loinc.org | S' wave duration in lead V3 |
|
100784-8
|
http://loinc.org | Feeling sad |
|
100785-5
|
http://loinc.org | Feeling people dislike me |
|
100786-3
|
http://loinc.org | Lack of energy |
|
100787-1
|
http://loinc.org | Total Score CES-D |
|
100788-9
|
http://loinc.org | Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum |
|
100789-7
|
http://loinc.org | Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100792-1
|
http://loinc.org | Forsythia IgE Ab [Units/volume] in Serum |
|
100793-9
|
http://loinc.org | Testosterone [Mass/volume] in Body fluid |
|
100794-7
|
http://loinc.org | Follitropin [Units/volume] in Body fluid |
|
100795-4
|
http://loinc.org | S100 calcium binding protein B [Mass/volume] in Body fluid |
|
100796-2
|
http://loinc.org | Thyroglobulin [Mass/volume] in Body fluid |
|
100797-0
|
http://loinc.org | Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge |
|
100798-8
|
http://loinc.org | Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge |
|
100799-6
|
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge |
|
|
http://loinc.org |
|
|
10080-0
|
http://loinc.org | S' wave duration in lead V5 |
|
100800-2
|
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge |
|
100801-0
|
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge |
|
100802-8
|
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge |
|
100803-6
|
http://loinc.org | 21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge |
|
100804-4
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge |
|
100805-1
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge |
|
100806-9
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge |
|
100807-7
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge |
|
100808-5
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge |
|
100809-3
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge |
|
100810-1
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge |
|
100811-9
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge |
|
100812-7
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge |
|
100813-5
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge |
|
100814-3
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge |
|
100815-0
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge |
|
100816-8
|
http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
100817-6
|
http://loinc.org | Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
10081-8
| http://loinc.org | S' wave duration in lead V6 |
|
100818-4
|
http://loinc.org | Renin [Mass/volume] in Plasma --1st specimen post XXX challenge |
|
100819-2
|
http://loinc.org | Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
|
|
http://loinc.org |
|
|
100820-0
|
http://loinc.org | Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
|
100821-8
|
http://loinc.org | National POLST form: portable medical order panel |
|
100822-6
|
http://loinc.org | Cardiopulmonary resuscitation orders |
|
100823-4
|
http://loinc.org | Initial portable medical treatment orders |
|
100824-2
|
http://loinc.org | Additional portable medical orders or instructions |
|
100825-9
|
http://loinc.org | Medically assisted nutrition orders |
|
10082-6
| http://loinc.org | ST initial amplitude 6 ms in lead AVF |
|
100826-7
|
http://loinc.org | Portable medical order AndOr advance directive review |
|
100827-5
|
http://loinc.org | Portable medical order discussion participants |
|
100828-3
|
http://loinc.org | Portable medical order administrative information |
|
100829-1
|
http://loinc.org | Renin [Mass/volume] in Plasma --4th specimen post XXX challenge |
|
100830-9
|
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge |
|
100831-7
|
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
|
100832-5
|
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
|
100833-3
|
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
|
10083-4
| http://loinc.org | ST initial amplitude 6 ms in lead AVL |
|
100834-1
|
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
|
100835-8
|
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
|
100836-6
|
http://loinc.org | Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
|
100837-4
|
http://loinc.org | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
100838-2
|
http://loinc.org | Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
|
100839-0
|
http://loinc.org | Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma |
|
100840-8
|
http://loinc.org | IgE [Units/volume] in Body fluid |
|
100841-6
|
http://loinc.org | Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot |
|
10084-2
|
http://loinc.org | ST initial amplitude 6 ms in lead AVR |
|
100842-4
|
http://loinc.org | Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST |
|
100843-2
|
http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile3+ |
|
100844-0
|
http://loinc.org | Liver fibrosis score in Serum or Plasma by Calculated.Agile4 |
|
100845-7
|
http://loinc.org | Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC) |
|
100846-5
|
http://loinc.org | Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
100847-3
|
http://loinc.org | Gas and ammonia panel - Arterial blood |
|
100848-1
|
http://loinc.org | Cell count and Differential panel - Amniotic fluid by Manual count |
|
100849-9
|
http://loinc.org | Leukocytes [#/volume] in Amniotic fluid by Manual count |
|
100850-7
|
http://loinc.org | Neutrophils [#/volume] in Amniotic fluid by Manual count |
|
100851-5
|
http://loinc.org | Other cells [#/volume] in Amniotic fluid by Manual count |
|
100852-3
|
http://loinc.org | NM Bones Views for metastasis W Sr-89 IV |
|
100853-1
|
http://loinc.org | NM Pericardial space Pericardial effusion |
|
100854-9
|
http://loinc.org |
|
|
100855-6
|
http://loinc.org |
CD3
|
|
100856-4
|
http://loinc.org |
CD3+CD4+
(T4
helper)
|
|
100857-2
|
http://loinc.org |
CD3+CD8+
(T8
suppressor)
|
|
100858-0
|
http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100860-6
|
http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide |
|
100861-4
|
http://loinc.org | Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
|
100862-2
|
http://loinc.org | Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
|
100863-0
|
http://loinc.org | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide |
|
100864-8
|
http://loinc.org | Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method |
|
100865-5
|
http://loinc.org | Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection |
|
100866-3
|
http://loinc.org | Febrile antibody profile in Serum |
|
10086-7
| http://loinc.org | ST initial amplitude 6 ms in lead II |
|
100867-1
|
http://loinc.org | Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay |
|
100868-9
|
http://loinc.org | Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method |
|
100869-7
|
http://loinc.org | Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method |
|
100870-5
|
http://loinc.org | Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method |
|
100871-3
|
http://loinc.org | Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method |
|
100872-1
|
http://loinc.org | Bacteria producing polysaccharide from sucrose [Presence] in Isolate |
|
100873-9
|
http://loinc.org | Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method |
|
100874-7
|
http://loinc.org | Basidiobolus sp [Presence] in Specimen |
|
10087-5
| http://loinc.org | ST initial amplitude 6 ms in lead III |
|
100875-4
|
http://loinc.org | Fetal Heart Document limited US |
|
100876-2
|
http://loinc.org | Fetal Heart Document US |
|
100877-0
|
http://loinc.org | US Heart Transesophageal during surgery |
|
100878-8
|
http://loinc.org | Endoscopic ultrasound study Upper GI tract Document |
|
100879-6
|
http://loinc.org | US Guidance for cryoablation of Breast - right |
|
100880-4
|
http://loinc.org | US Guidance for cryoablation of Breast - left |
|
100881-2
|
http://loinc.org | MR Guidance for cryoablation of Bone |
|
100882-0
|
http://loinc.org | MR Peritoneum W contrast percutaneous intraperitoneal |
|
10088-3
| http://loinc.org | ST initial amplitude 6 ms in lead V1 |
|
100883-8
|
http://loinc.org | MR Guidance for biopsy of Kidney - left |
|
100884-6
|
http://loinc.org | MR Guidance for biopsy of Kidney - right |
|
100885-3
|
http://loinc.org | Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection |
|
100886-1
|
http://loinc.org | Orf virus DNA [Presence] in Specimen by NAA with probe detection |
|
100887-9
|
http://loinc.org | Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection |
|
100888-7
|
http://loinc.org |
|
|
100889-5
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
|
http://loinc.org |
|
|
100891-1
|
http://loinc.org | Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
100892-9
|
http://loinc.org | Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
|
100893-7
|
http://loinc.org | Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma |
|
100894-5
|
http://loinc.org | Recommended screening frequency Narrative |
|
100895-2
|
http://loinc.org | Rickettsia conorii IgG and IgM [Interpretation] in Serum |
|
100896-0
|
http://loinc.org | Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge |
|
100897-8
|
http://loinc.org | Staphylococcus aureus [Presence] in Specimen by Organism specific culture |
|
100898-6
|
http://loinc.org | Lipid panel - Serum or Plasma |
|
100899-4
|
http://loinc.org | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture |
Additional Language Displays
| Code | Deutsch (Österreich) (German (Austria), de) |
|
|
|
|
|
|
Portuguese (Brazil) (pt) |
|
|
|
|
Health Info Pioneer+Father of LOINC | |||||||
|
|
|
Health Info Pioneer+Cofound LOINC |
|
|
|
||||
|
|
Specimen care is maintained |
|
|
||||||
|
|
Team communication is maintained throughout care | ||||||||
|
|
Demonstrates knowledge of the expected psychosocial responses to the procedure | ||||||||
|
|
Demonstrates knowledge of nutritional management related to the procedure | ||||||||
|
|
Demonstrates knowledge of medication management | ||||||||
|
|
Demonstrates knowledge of pain management | ||||||||
|
|
R wave dur L-AVR | duración de la onda R.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. Lead AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-AVR | |||||
| 100008-2 | Demonstrates knowledge of wound management | ||||||||
| 100009-0 | Demonstrates knowledge of the procedure and expected results | ||||||||
|
|
No injury related to procedure equipment, medical supplies, or instrumentation |
|
|
||||||
|
|
No injury related to an electrical source | ||||||||
|
|
Participates in decisions affecting the patient's plan of care | ||||||||
|
|
Participates in the discharge process | ||||||||
|
|
Psychosocial health is maintained at or improved from baseline | ||||||||
|
|
No injury related to positioning due to care or procedure | ||||||||
|
|
R wave dur L-I | duración de la onda R.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-I | |||||
| 100016-5 | No injury related to a laser source | ||||||||
| 100017-3 | Perioperative nursing data set outcomes panel [PNDS] | ||||||||
| 100018-1 | Hospice care Note | Verslag [bevinding] in {instelling} d.m.v. hospicezorg (document) | |||||||
| 100019-9 | ALK gene targeted mutation analysis, Blood or tissue specimen |
|
ALK gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | ALK-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
|
|
|
|
|
|
|||||
|
|
GNAQ gene targeted mutation analysis, Blood or tissue specimen | GNAQ gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | GNAQ-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | ||||||
|
|
IDH1 gene targeted mutation analysis, Blood or tissue specimen | IDH1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | IDH1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | ||||||
|
|
IDH2 gene targeted mutation analysis, Blood or tissue specimen |
|
IDH2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | IDH2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
|
|
|
|
Duración de la onda R. derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-II | |||||
| 100024-9 | SETBP1 gene targeted mutation analysis, Blood or tissue specimen |
|
SETBP1 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SETBP1-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100025-6 | SRSF2 gene targeted mutation analysis, Blood or tissue specimen |
|
SRSF2 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SRSF2-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100026-4 | MET gene targeted mutation analysis, Blood or tissue specimen |
|
MET gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | MET-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100027-2 |
|
SMAD4 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | SMAD4-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | ||||||
| 100028-0 | FBXW7 gene targeted mutation analysis, Blood or tissue specimen |
|
FBXW7 gène mutation cible trouvée [Identification] Sang/Tissu ; Résultat nominal ; Biologie moléculaire | FBXW7-gen doelgerichte mutatie-analyse [identificator] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | |||||
| 100029-8 | Cancer related multigene analysis (cfDNA) |
|
Analyse multigénique en relation avec le cancer [Recherche] Plasma avec ADN libre circulant ; Document ; Biologie moléculaire | Kankergerelateerde multigen-analyse [bevinding] in plasma.celvrij DNA d.m.v. moleculair genetisch onderzoek (document) | |||||
|
|
Axis I: Temporal aspects score [Mainz Pain Staging System] |
|
|
||||||
|
|
Axis II: Spatial aspects score [Mainz Pain Staging System] | ||||||||
|
|
R wave dur L-III | duración de la onda R.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R. derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-III | |||||
| 100032-2 | Axis III: Drug taking behavior score [Mainz Pain Staging System] | ||||||||
| 100033-0 | Axis IV: Utilization of the health care system score [Mainz Pain Staging System] | ||||||||
| 100034-8 | Provider of AED | ||||||||
| 100035-5 | Exam finding location Chest |
|
|||||||
| 100036-3 | Exam finding location Lung |
|
|||||||
| 100037-1 | Patient contact disposition EMS unit | ||||||||
| 100038-9 | Patient eval disposition EMS unit | ||||||||
| 100039-7 | Crew disposition EMS unit | ||||||||
| 10004-0 | R wave dur L-V1 | duración de la onda R.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100040-5 | Pt transport disposition EMS unit | ||||||||
| 100041-3 | Aminoglycosid-Empfindlichkeit | Aminoglycosid [Empfindlichkeit] |
|
Aminoglycoside [Sensibilité] Isolat ; Alphanumérique | |||||
| 100042-1 | Atovaquon-Empfindlichkeit |
|
Atovaquone [Sensibilité] Isolat ; Alphanumérique |
|
|||||
| 100043-9 | Azithromycin/Ethambutol-Empfindlichkeit |
|
|
Azithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique |
|
||||
| 100044-7 | Cefcapene-Empfindlichkeit | Cefcapen [Empfindlichkeit] |
|
Cefcapene [Sensibilité] Isolat ; Alphanumérique | Cefcapeen [gevoeligheid] in isolaat | ||||
| 100045-4 | Cefozopran-Empfindlichkeit |
|
Céfozopran [Sensibilité] Isolat ; Alphanumérique |
|
|
||||
| 100046-2 | Cefquinom-Empfindlichkeit |
|
Cefquinome [Sensibilité] Isolat ; Alphanumérique | Cefquinome [gevoeligheid] in isolaat | |||||
| 100047-0 | Cefteram-Empfindlichkeit |
|
Cefteram [Sensibilité] Isolat ; Alphanumérique | Cefteram [gevoeligheid] in isolaat | |||||
| 100048-8 | Clarithromycin/Ethambutol-Empfindlichkeit |
|
|
Clarithromycine+éthambutol [Sensibilité] Isolat ; Alphanumérique |
|
||||
| 100049-6 | Eravacycline-Empfindlichkeit | Eravacyclin [Empfindlichkeit] |
|
Éravacycline [Sensibilité] Isolat ; Alphanumérique | Eravacycline [gevoeligheid] in isolaat | ||||
|
|
Erythromycin/Ethambutol-Empfindlichkeit | Erythromycin+Ethambutol [Empfindlichkeit] |
|
|
|
|
|||
|
|
|
Ethambutol+Rifampicin [Empfindlichkeit] |
|
Éthambutol+rifampicine [Sensibilité] Isolat ; Alphanumérique |
|
|
|||
|
|
|
Flomoxef [Empfindlichkeit] |
|
Flomoxef [Sensibilité] Isolat ; Alphanumérique |
|
||||
|
|
Fluoroquinolon-Empfindlichkeit | Fluorchinolon [Empfindlichkeit] |
|
Fluoroquinolone [Sensibilité] Isolat ; Alphanumérique |
|
|
|||
|
|
Gamithromycin-Empfindlichkeit |
|
Gamithromycine [Sensibilité] Isolat ; Alphanumérique | ||||||
|
|
Optochin-Empfindlichkeit | Optochin [Empfindlichkeit] |
|
Optochine [Sensibilité] Isolat ; Alphanumérique | Optochine [gevoeligheid] in isolaat | ||||
|
|
Panipenem-Empfindlichkeit | Panipenem [Empfindlichkeit] |
|
Panipénème [Sensibilité] Isolat ; Alphanumérique |
|
||||
|
|
R wave dur L-V2 |
|
Duración de la onda R. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG |
|
|||||
| 100057-9 | Prothionamid-Empfindlichkeit | Prothionamid [Empfindlichkeit] |
|
Protionamide [Sensibilité] Isolat ; Alphanumérique |
|
|
|||
| 100058-7 | Prulifloxacin-Empfindlichkeit | Prulifloxacin [Empfindlichkeit] |
|
Prulifloxacine [Sensibilité] Isolat ; Alphanumérique | Prulifloxacine [gevoeligheid] in isolaat | ||||
| 100059-5 | Rifapentin-Empfindlichkeit | Rifapentin [Empfindlichkeit] |
|
Rifapentine [Sensibilité] Isolat ; Alphanumérique | Rifapentine [gevoeligheid] in isolaat | ||||
|
|
Tildipirosin-Empfindlichkeit | Susceptibility to Tildipirosin | Tildipirosine [Sensibilité] Isolat ; Alphanumérique |
|
|
||||
|
|
Tosufloxacin-Empfindlichkeit | Tosufloxacin [Empfindlichkeit] |
|
Tosufloxacine [Sensibilité] Isolat ; Alphanumérique | Tosufloxacine [gevoeligheid] in isolaat | ||||
|
|
|
||||||||
|
|
Primary skin concern | ||||||||
|
|
Itch severity RptPeriod Reported | ||||||||
|
|
R wave dur L-V3 |
|
Duración de la onda R. derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V3 | |||||
| 100065-2 | Satisfied with treatment | ||||||||
| 100066-0 | Specular microscopy panel |
|
Endotheelcelmicroscopie panel in oog d.m.v. endotheelcelmicroscopie | ||||||
| 100067-8 | Eye Image magnification | ||||||||
| 100068-6 | R eye Fixation point [Angle] | ||||||||
| 100069-4 | L eye Fixation point [Angle] | ||||||||
|
|
R cornea Cell density |
|
|
||||||
|
|
L cornea Cell density | ||||||||
|
|
R cornea Coefficient of variation | ||||||||
|
|
R wave dur L-V4 |
|
Duración de la onda R. derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V4 | |||||
| 100073-6 | L cornea Coefficient of variation | ||||||||
| 100074-4 | R cornea Hexagonality | ||||||||
| 100075-1 | L cornea Hexagonality | ||||||||
| 100076-9 | R cornea Endothelial cells counted | ||||||||
| 100077-7 | L cornea Endothelial cells counted | ||||||||
| 100078-5 | R cornea Endothelial cell area.min | ||||||||
| 100079-3 | L cornea Endothelial cell area.min | ||||||||
|
|
R cornea Endothelial cell area.max |
|
|
||||||
|
|
R wave dur L-V5 |
|
Duración de la onda R. Plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V5 | |||||
| 100081-9 | L cornea Endothelial cell area.max | ||||||||
| 100082-7 | R cornea Endothelial cell area.mean | ||||||||
| 100083-5 | L cornea Endothelial cell area.mean | ||||||||
| 100084-3 | R cornea Cell area.sd | ||||||||
| 100085-0 | L cornea Cell area.sd | ||||||||
| 100086-8 | R cornea Analysis method | ||||||||
| 100087-6 |
|
|
Toxocara canis 24-35kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxocara canis 24-35kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100088-4 |
|
|
Taenia solium cysticerque Ac bandes panel [-] Sérum ; - ; Immunoblot | Taenia solium larve As banden panel in serum d.m.v. immunoblotting | |||||
| 100089-2 | Taenia solium larva 6-8kD antibody, Blood |
|
Taenia solium cysticerque 6-8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Taenia solium larve 6-8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
DBG antibody, Blood Product Unit |
|
DBG Ab: Suero o plasma Unidad de hemoderivado: Punto temporal: Presencia o umbral: Ordinal: |
|
|
||||
| 100090-0 | Taenia solium larva 45kD antibody, Blood |
|
Taenia solium cysticerque 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Taenia solium larve 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100091-8 |
|
|
Trypanosoma cruzi Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse |
|
|
||||
| 100092-6 |
|
|
Trypanosoma cruzi Ac bandes panel [-] Sérum ; - ; Immunoblot | Trypanosoma cruzi As banden panel in serum d.m.v. immunoblotting | |||||
| 100093-4 |
|
|
Trypanosoma cruzi 15-16kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 15-16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100094-2 |
|
|
Trypanosoma cruzi 21-22kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 21-22kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100095-9 |
|
|
Trypanosoma cruzi 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100096-7 |
|
|
Trypanosoma cruzi 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100097-5 |
|
|
Trypanosoma cruzi 45-47kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 45-47kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100098-3 |
|
|
Trypanosoma cruzi 120-200kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Trypanosoma cruzi 120-200kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
|
|
Duración de la onda R. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R onda dur L-V6 | |||||
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
Fasciola 27-28kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 27-28kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
|
|
Fasciola 60kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 60kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
|
|
Fasciola 42kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Fasciola sp. 42kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
|
|
Filaria Ac IgG et IgM panel [-] Sérum ; - | Filaria As.IgG & IgM panel in serum | |||||
|
|
|
Filaria Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Filaria As.IgG [aanwezigheid] in serum d.m.v. immunoassay | ||||||
|
|
|
|
|
|
|||||
| 100107-2 |
|
|
|
||||||
| 100108-0 |
|
|
|
|
|||||
| 100109-8 |
|
|
Leishmania Ac bandes panel [-] Sérum ; - ; Immunoblot | Leishmania sp. As banden panel in serum d.m.v. immunoblotting | |||||
|
|
|
|
|
|
|||||
|
|
|
|
Leishmania 16 kD Ac IgG [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Leishmania sp. 16kD As.IgG [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
Fasciola sp Ab bands panel, Blood |
|
Fasciola Ac bandes panel [-] Sérum ; - ; Immunoblot | Fasciola sp. As-banden panel in serum d.m.v. immunoblotting | |||||
|
|
|
|
Helicobacter pylori Ac panel [-] Sérum ; - | Helicobacter pylori As panel in serum | |||||
|
|
|
Toxoplasma gondii 30kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 30kD As [aanwezigheid] in serum d.m.v. immunoblotting | ||||||
|
|
|
|
Amplitud de onda R 'plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVL | |||||
| 100115-5 | Toxoplasma gondii 31kD antibody, Blood |
|
Toxoplasma gondii 31kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 31kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100116-3 | Toxoplasma gondii 33kD antibody, Blood |
|
Toxoplasma gondii 33kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 33kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100117-1 | Toxoplasma gondii 40kD antibody, Blood | Toxoplasma gondii 40kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 40kD As [aanwezigheid] in serum d.m.v. immunoblotting | ||||||
| 100118-9 | Toxoplasma gondii 41kD antibody, Blood |
|
Toxoplasma gondii 41kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 41kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100119-7 | Toxoplasma gondii 45kD antibody, Blood |
|
Toxoplasma gondii 45kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Toxoplasma gondii 45kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
|
|
|
|
|||||
|
|
Chlamydia trachomatis IgA-Antikörper [Nachweis] in Serum mittels Immunoassay |
|
Chlamydia trachomatis Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse | Chlamydia trachomatis As.IgA [aanwezigheid] in serum d.m.v. immunoassay | Chlamydia trachomatis Антитіла.IgA ІА (Свтк) [НвнПор] | ||||
|
|
|
|
|
Chlamydia pneumoniae Ac panel [-] Sérum ; - |
|
|
|||
|
|
|
amplitud de la onda R'.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'plomo AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-AVR | |||||
| 100123-9 |
|
|
Chlamydia pneumoniae Ac IgA [Présence/Seuil] Sérum ; Qualitatif ; Immunoanalyse |
|
|
||||
| 100124-7 |
|
|
Chlamydia pneumoniae Ac IgA [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse |
|
|
||||
| 100125-4 |
|
Chlamydia psittaci Ac panel [-] Sérum ; - | Chlamydophila psittaci As panel in serum | ||||||
| 100126-2 | Bordetella pertussis Ab.IgG panel, Blood |
|
Bordetella pertussis Ac IgG panel [-] Sérum ; - | Bordetella pertussis As.IgG panel in serum | |||||
| 100127-0 |
|
Campylobacter Ac panel [-] Sérum ; - | Campylobacter sp. As panel in serum | ||||||
| 100128-8 |
|
|
Cryptococcus Ag panel [-] Sérum ; - | Cryptococcus sp. Ag panel in serum | |||||
| 100129-6 |
|
|
Schistosoma Ac [Titre] Sérum ; Semi-Quantitatif ; Hémagglutination | Schistosoma sp. As [titer] in serum d.m.v. hemagglutinatie |
|
||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
| 100131-2 | Schistosoma sp 8kD antibody, Blood |
|
Schistosoma 8kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 8kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100132-0 | Schistosoma sp 9kD antibody, Blood |
|
Schistosoma 9kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 9kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100133-8 | Schistosoma sp 10kD antibody, Blood |
|
Schistosoma 10kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 10kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100134-6 | Schistosoma sp 11kD antibody, Blood |
|
Schistosoma 11kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 11kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100135-3 | Schistosoma sp 12-13kD antibody, Blood |
|
Schistosoma 12-13kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 12-13kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100136-1 | Schistosoma sp 14-15kD antibody, Blood |
|
Schistosoma 14-15kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 14-15kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100137-9 | Schistosoma sp 15-16kD antibody, Blood |
|
Schistosoma 15-16kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 15-16kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100138-7 | Schistosoma sp 18-19kD antibody, Blood |
|
Schistosoma 18-19kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 18-19kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
| 100139-5 | Schistosoma sp 22-24kD antibody, Blood |
|
Schistosoma 22-24kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 22-24kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
|
|
|
|
|||||
|
|
Schistosoma sp 65kD antibody, Blood |
|
Schistosoma 65kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 65kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
Schistosoma sp 70kD antibody, Blood |
|
Schistosoma 70kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 70kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
Schistosoma sp 80kD antibody, Blood |
|
Schistosoma 80kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 80kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
Schistosoma sp 95kD antibody, Blood |
|
Schistosoma 95kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 95kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
Schistosoma sp 110kD antibody, Blood |
|
Schistosoma 110kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 110kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
Schistosoma sp 120kD antibody, Blood |
|
Schistosoma 120kD Ac [Présence/Seuil] Sérum ; Qualitatif ; Immunoblot | Schistosoma sp. 120kD As [aanwezigheid] in serum d.m.v. immunoblotting | |||||
|
|
Toxoplasma gondii Ab bands panel, Blood |
|
Toxoplasma gondii Ac bandes panel [-] Sérum ; - ; Immunoblot | Toxoplasma gondii As banden panel in serum d.m.v. immunoblotting | |||||
|
|
Schistosoma sp Ab bands panel, Blood |
|
Schistosoma Ac bandes panel [-] Sérum ; - ; Immunoblot | Schistosoma sp. As banden panel in serum d.m.v. immunoblotting | |||||
|
|
|
|
Amplitud de onda R 'derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-II | |||||
| 100149-4 |
|
6-oxo-pipéridine-2-carboxylate et 6(R+S)-oxo-propylpipéridine-2-carboxylate panel [-] Urine+Sérum/Plasma ; - | 6-oxo-piperidine-2-carboxylaat & 6(R+S)-oxo-propylpiperidine-2-carboxylaat in urine en serum of plasma | ||||||
|
|
|
|
|
|
|||||
|
|
6-oxo-piperidine-2-carboxylate, Blood | 6-oxo-pipéridine-2-carboxylate [Moles/Volume] Plasma ; Numérique | 6-oxo-piperidine-2-carboxylaat [mol/volume] in plasma | ||||||
|
|
|
6-oxo-pipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique | 6-oxo-piperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | ||||||
|
|
6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine, Urine |
|
6(R+S)-oxo-propylpipéridine-2-carboxylate/créatinine [Moles ratio] Urine ; Numérique | 6(R+S)-oxo-propylpiperidine-2-carboxylaat/creatinine [molaire verhouding] in urine | |||||
|
|
Collection supervision level, Specimen | Niveau de supervision du recueil [Recherche] Prélèvement ; Résultat nominal | |||||||
|
|
L cornea Analysis method | ||||||||
|
|
R' wave Amp L-III |
|
Amplitud de onda R 'derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-III | |||||
| 100156-9 | SARS-CoV-2 (COVID-19)-Variante [Typ] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion |
|
|
Coronavirus SARS-CoV-2 variant [Type] Milieux divers ; Résultat nominal ; PCR amplification de cible | SARS-CoV-2-variant [type] d.m.v. probe-detectie | ||||
| 100157-7 | SARS-CoV-2 (COVID-19)-Abstammungslinie [Typ] in Probenmaterial mittels Sequenzierung |
|
|
Coronavirus SARS-CoV-2 lignée [Type] Milieux divers ; Résultat nominal ; Séquençage | SARS-CoV-2 lineage [type] d.m.v. sequencing | ||||
| 100158-5 | Albumin, Urine |
|
|
||||||
| 100159-3 | Knee Society Score pre-op panel [Knee Society Score] | ||||||||
|
|
Knee replacement |
|
|
||||||
|
|
Charnley Functional Classification | ||||||||
|
|
Alignment W Stand Knee XR | ||||||||
|
|
Knee medial AndOr lateral instability W full extension | ||||||||
|
|
R' wave Amp L-V1 | amplitud de la onda R'.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V1 | |||||
| 100164-3 | Knee AP instability W 90 degree flexion | ||||||||
| 100165-0 | Knee Qn | ||||||||
| 100166-8 | Flexion contracture range Knee | ||||||||
| 100167-6 | Extensor lag range Knee | ||||||||
| 100168-4 | Knee pain severity with level walking | ||||||||
| 100169-2 | Knee pain severity with stairs or inclines | ||||||||
|
|
DBG antibody, Donor Blood |
|
DBG Ab: Suero o plasma Donante: Punto temporal: Presencia o umbral: Ordinal: |
|
|
||||
| 100170-0 | Knee feels normal | ||||||||
| 100171-8 | Satisfaction with level of knee pain while sitting | ||||||||
| 10017-2 |
|
amplitud de la onda R'.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V2 | |||||
| 100172-6 | Satisfaction with level of knee pain while lying in bed | ||||||||
| 100173-4 | Satisfaction with knee function while getting out of bed | ||||||||
| 100174-2 | Satisfaction with knee function while performing light household duties | ||||||||
| 100175-9 | Satisfaction with knee function while performing recreational activities | ||||||||
| 100176-7 | Expect surgery to relieve pain | ||||||||
| 100177-5 | Expect surgery will improve ability to perform activities of daily living | ||||||||
| 100178-3 | Expect surgery will improve ability to perform leisure, recreational, or sports activities | ||||||||
| 100179-1 | Walk without assistive mobility devices | ||||||||
| 10018-0 | R' wave Amp L-V3 | amplitud de la onda R'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100180-9 | Assistive mobility devices used | ||||||||
| 100181-7 | Assistive mobility devices used due to health condition | ||||||||
| 100182-5 | Duration of standing before sitting due to knee discomfort | ||||||||
| 100183-3 | Duration of walking before stopping due to knee discomfort | ||||||||
| 100184-1 | How bothersome is knee when walking on an uneven surface | ||||||||
| 100185-8 | How bothersome is knee when turning or pivoting leg | ||||||||
| 100186-6 | How bothersome is knee when climbing up or down a flight of stairs | ||||||||
| 100187-4 | How bothersome is knee when getting up from a low seat without armrests | ||||||||
| 100188-2 | How bothersome is knee when getting into or out of a car | ||||||||
| 100189-0 | How bothersome is knee when moving laterally |
|
|||||||
| 100190-8 | How bothersome is knee when climbing a ladder or step stool | ||||||||
| 100191-6 | How bothersome is knee when carrying a bag for one block | ||||||||
| 100192-4 | How bothersome is knee when squatting | ||||||||
| 100193-2 | How bothersome is knee when kneeling | ||||||||
| 100194-0 | How bothersome is knee when running | ||||||||
| 100195-7 | Pain severity--during activity | ||||||||
| 100196-5 | Pre-op total score [Knee Society Score] | ||||||||
| 100197-3 | Exercise activity and pain severity panel | ||||||||
|
|
R' wave Amp L-V4 | amplitud de la onda R'.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V4 | |||||
|
|
Pre-op objective knee indicators score [Knee Society Score] | ||||||||
|
|
Pre-op symptoms score [Knee Society Score] |
|
|
|
|
|
|||
|
|
Pre-op patient expectations score [Knee Society Score] |
|
|
||||||
|
|
Pre-op functional activities score [Knee Society Score] | ||||||||
|
|
Pre-op discretionary knee activities score [Knee Society Score] | ||||||||
|
|
Knee Society Score post-op panel [Knee Society Score] | ||||||||
|
|
Accuracy of pre-surgery expectations of pain relief | ||||||||
|
|
Accuracy of pre-surgery expectations to perform activities of daily living | ||||||||
|
|
R' wave Amp L-V5 | amplitud de la onda R'.derivación V5:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V5:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V5 | |||||
| 100206-2 | Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities | ||||||||
| 100207-0 | Post-op total score [Knee Society Score] | ||||||||
| 100208-8 | Post-op objective knee indicators score [Knee Society Score] | ||||||||
| 100209-6 | Post-op symptoms score [Knee Society Score] | ||||||||
|
|
Post-op patient expectations score [Knee Society Score] |
|
|
||||||
|
|
Post-op functional activities score [Knee Society Score] | ||||||||
|
|
Post-op discretionary knee activities score [Knee Society Score] | ||||||||
|
|
Prostate cancer multigene analysis, Blood or tissue specimen | Analyse multigénique du cancer de la prostate [Recherche] Sang/Tissu ; Document ; Biologie moléculaire | Multigen-analyse op prostaatkanker [bevinding] in bloed of weefsel d.m.v. moleculair genetisch onderzoek (document) | ||||||
|
|
R' wave Amp L-V6 | amplitud de la onda R'.derivación V6:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda R 'derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | R' onda Amp L-V6 | |||||
| 100214-6 | Dental model prior auth Doc | ||||||||
| 100215-3 | Episode of care med rec Doc Transpl surg | Verslag van zorgepisode [bevinding] d.m.v. transplantatiechirurgie (document) | |||||||
| 100216-1 | Surgical synoptic report | Beknopt rapport [bevinding] d.m.v. chirurgie (tekstueel) | |||||||
| 100217-9 | Synoptic report Surg Onc | ||||||||
| 100218-7 | Surg onc colon CA synoptic rep | ||||||||
| 100219-5 | Surg onc melanoma CA synoptic rep | ||||||||
|
|
Surg onc breast CA synoptic rep |
|
|
||||||
|
|
Surg onc thyroid CA synoptic rep | ||||||||
|
|
R' wave dur L-AVF |
|
Duración de la onda R 'plomo AVF:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVF | |||||
| 100222-9 | Surg onc pancreas CA synoptic rep | ||||||||
| 100223-7 | Retina Phys find |
|
|||||||
| 100224-5 | Cardiac LV SWM Pnl LV US | ||||||||
| 100225-2 | Bone density QUS | ||||||||
| 100226-0 | Sm bowel capsule endo study Doc | ||||||||
| 100227-8 | Colon capsule endo study Doc | ||||||||
| 100228-6 | UGI capsule endo study Doc | ||||||||
| 100229-4 | Endo US study Doc | ||||||||
| 10023-0 | R' wave dur L-AVL | duración de la onda R'.derivación AVL:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100230-2 | Routine prenatal pnl | ||||||||
| 100231-0 | EBUS study | ||||||||
| 100232-8 | Impacts of Events Scale-Revised panel | ||||||||
| 100233-6 | Reminders brought back feelings about adverse event | ||||||||
| 100234-4 | Trouble staying asleep | ||||||||
| 100235-1 | Other things triggered persistent thoughts about adverse event | ||||||||
| 100236-9 | Felt irritable AndOr angry | ||||||||
| 100237-7 | Avoided getting upset when unintentionally thought about adverse event | ||||||||
| 100238-5 | Thought about adverse event unintentionally | ||||||||
| 100239-3 | Felt as if adverse event did not happen | ||||||||
|
|
Avoided reminders of adverse event |
|
|
||||||
|
|
Experienced mental images of adverse event | ||||||||
|
|
Easily startled | ||||||||
|
|
Tried to not think of adverse event | ||||||||
|
|
Aware of feelings about adverse event, but did not address them | ||||||||
|
|
Feelings about adverse event were numb | ||||||||
|
|
Acted or felt the same as during adverse event | ||||||||
|
|
Trouble falling asleep | ||||||||
|
|
R' wave dur L-AVR | duración de la onda R'.derivación AVR:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo AVR:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-AVR | |||||
| 100248-4 | Waves of strong feelings about adverse event | ||||||||
| 100249-2 | Tried to remove adverse event from memory | ||||||||
|
|
DBG antibody, Blood |
|
DBG Ab: Suero o Plasma : Punto temporal: Presencia o umbral: Ordinal: |
|
|
||||
| 100250-0 | Trouble concentrating | ||||||||
| 100251-8 | Reminders of adverse event caused physical reactions | ||||||||
| 100252-6 | Had dreams about adverse event | ||||||||
| 100253-4 | Felt watchful and on-guard | ||||||||
| 100254-2 | Tried not to talk about adverse event | ||||||||
|
|
R' wave dur L-I | duración de la onda R'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R '.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-I | |||||
|
|
Total score [Impact of Event Scale-Revised] | ||||||||
|
|
Fallen in last 6Mo | ||||||||
|
|
Feel unsteady when standing or walking | ||||||||
|
|
History of fall related injury | ||||||||
|
|
Aware of tactile sensations |
|
|
||||||
| 100260-9 | Easy to describe thoughts AndOr feelings | ||||||||
| 100261-7 | Critical of own thoughts AndOr feelings | ||||||||
| 100262-5 | Able to notice distressing thoughts AndOr feelings without having to react | ||||||||
|
|
R' wave dur L-II | duración de la onda R'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-II | |||||
|
|
Easily distracted | ||||||||
|
|
Able to notice thoughts AndOr feelings without being overwhelmed | ||||||||
|
|
Aware of dietary intake impact on self | ||||||||
|
|
Difficult to describe thoughts AndOr feelings | ||||||||
|
|
Aware of auditory stimuli | ||||||||
|
|
Able to avoid immediate reaction in difficult situations | ||||||||
|
|
Do things without paying attention |
|
|
||||||
| 100270-8 | Recover quickly from distressing thoughts AndOr images | ||||||||
|
|
R' wave dur L-III | duración de la onda R'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-III | |||||
|
|
Aware of olfactory stimuli | ||||||||
|
|
Aware of visual stimuli | ||||||||
|
|
Aware of emotions affect on thoughts AndOr behavior | ||||||||
|
|
Observing score [FFMQ] | ||||||||
|
|
Describing score [FFMQ] | ||||||||
|
|
Acting with awareness score [FFMQ] | ||||||||
|
|
Nonjudging score [FFMQ] | ||||||||
|
|
Nonreactivity score [FFMQ] | ||||||||
|
|
Total score [FFMQ] |
|
|
||||||
| 100280-7 | Five Facet Mindfulness Questionnaire panel [FFMQ] | ||||||||
| 100281-5 |
|
|
RH1 (D) anticorps [Arbitraire/Volume] Sérum/Plasma ; Numérique |
|
|
||||
| 100282-3 | Vaccine exemption cert | ||||||||
| 100283-1 | Harris Hip Score panel [Harris Hip Score] | ||||||||
| 100284-9 | Walking - functional ability | ||||||||
| 100285-6 | Comfortable seated position | ||||||||
| 100286-4 | Able to board public transportation | ||||||||
| 100287-2 | Put on shoes and socks | ||||||||
| 100288-0 | Absence of deformity score [Harris Hip Score] | ||||||||
|
|
R' wave dur L-V1 | duración de la onda R'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V1 | |||||
|
|
Absence of hip deformity measurements |
|
|
||||||
| 100290-6 | Range of motion score [Harris Hip Score] | ||||||||
| 100291-4 | Total score [Harris Hip Score] | ||||||||
| 100292-2 | Pre-op patient satisfaction score [Knee Society Score] | ||||||||
| 100293-0 | Hip Flexion range of motion | ||||||||
| 100294-8 | Hip Abduction range of motion | ||||||||
| 100295-5 | Hip Adduction range of motion | ||||||||
| 100296-3 | Hip External rotation range of motion | ||||||||
|
|
R' wave dur L-V2 | duración de la onda R'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V2 | |||||
|
|
Hip Internal rotation range of motion | ||||||||
|
|
Rep count | ||||||||
|
|
|
|
|
|
|
||||
|
|
End time |
|
|
||||||
|
|
Start time |
|
|||||||
|
|
Time start/end panel Spec |
|
|||||||
|
|
Condition certainty of presence | ||||||||
|
|
Flights climbed RptPeriod | ||||||||
|
|
R' wave dur L-V3 |
|
Duración de la onda R 'derivación V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V3 | |||||
| 100305-2 | IDH1 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH1 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaire | IDH1-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | ||||||
| 100306-0 | IDH2 gene exon 4 targeted mutation analysis, Blood Or Bone marrow | IDH2 gène exon 4 mutation cible trouvée [Présence/Seuil] Sang/Moelle osseuse ; Qualitatif ; Biologie moléculaire | IDH2-gen exon 4 doelgerichte mutatie-analyse [aanwezigheid] in bloed of beenmerg d.m.v. moleculair genetisch onderzoek | ||||||
| 100307-8 | Behavioral screening elder mistreatment | ||||||||
| 100308-6 | Need help getting to essential places | ||||||||
| 100309-4 | Activity support person | ||||||||
|
|
Reliability of support person |
|
|
||||||
|
|
Need help to make sure there is enough food, medicines or any other things needed in house | ||||||||
|
|
Person or persons that makes sure there is enough food, medicines or any other things needed in house | ||||||||
|
|
R' wave dur L-V4 | duración de la onda R'.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'derivación V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V4 | |||||
| 100313-6 | Need help with household things such as cook meals, help feed, or provide correct medicines each day | ||||||||
| 100314-4 | Need help with house cleaning or yard work | ||||||||
| 100315-1 | Need help getting out of bed, showered, or dressed | ||||||||
| 100316-9 | Need help to make sure bills get paid | ||||||||
| 100317-7 | Relationship of usual support person for daily activities | ||||||||
| 100318-5 | Have help with finances AndOr financial decisions | ||||||||
| 100319-3 | Relationship of financial support person | ||||||||
|
|
Financial support person usually asks for permission before making decisions |
|
|
||||||
|
|
R' wave dur L-V5 | duración de la onda R'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V5:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V5 | |||||
| 100321-9 | Financial support person usually makes good decisions about finances | ||||||||
| 100322-7 | Have access to paperwork for financial decisions made | ||||||||
| 100323-5 | Financial support person forged signature | ||||||||
| 100324-3 | Coercion of financial support person for signing a document in order to get money or possessions | ||||||||
| 100325-0 | Experienced theft by support person | ||||||||
| 100326-8 | Money spent or property sold without permission | ||||||||
| 100327-6 | Stranger forged signature for financial gain | ||||||||
| 100328-4 | Stranger forced document signature for financial gain | ||||||||
| 100329-2 | Feared for safety due to verbal attack | ||||||||
|
|
Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: |
|
Test indirect à l'antiglobuline (TIA) complément spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif |
|
|
|||
| 100330-0 | Felt humiliated due to ridicule | ||||||||
| 100331-8 | Coerced to do something | ||||||||
| 100332-6 | Ignored by close friend or relative for extended period | ||||||||
| 100333-4 | Physically hit or threatened | ||||||||
| 100334-2 | Been physically hurt with some degree of injury | ||||||||
| 100335-9 | Coerced sexual activity | ||||||||
| 100336-7 | Coerced touching of private body parts of self or others | ||||||||
| 100337-5 | Coerced to undress or expose private body area | ||||||||
| 100338-3 | Photographed in any degree of nudity without consent | ||||||||
|
|
R' wave dur L-V6 | duración de la onda R'.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda R 'plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | R' onda dur L-V6 | |||||
|
|
Experienced attempted physical restraint |
|
|
||||||
| 100340-9 | Range of motion panel Hip | ||||||||
| 100341-7 | Rötelnvirus Antikörper-Index |
|
|
|
Rubéole virus Ac IgG index [Arbitraire/Volume] Sérum+Liquide céphalorachidien ; Numérique |
|
|
||
| 100342-5 | Flüchtige organische Verbindungen assoziiert mit SARS-CoV-2-Infektion [Nachweis] in Exhalat mittels GC-MS | Volatile Organic Compounds associated with SARS-CoV-2 infection, Exhaled gas | Composés organiques volatiles associés à l'infection SARS-CoV-2 [Présence/Seuil] Gaz expiré ; Qualitatif ; GC-MS | Vluchtige organische componenten bij SARS-CoV-2-infectie [aanwezigheid] in uitgeademde lucht d.m.v. gaschromatografie-massaspectrometrie | |||||
| 100343-3 |
|
|
|
|
|||||
| 100344-1 |
|
|
|
|
|||||
| 100345-8 |
|
Influenza
virus
A
|
|
Influenza virus A et B et Coronavirus SARS-Cov-2 ARN panel [-] Milieux divers ; - ; PCR amplification de cible | Influenzavirus A & influenzavirus B & SARS-CoV-2 RNA panel d.m.v. probe-detectie | ||||
| 100346-6 | Clotting Time FIBTEM | Clotting time.extrinsic coagulation system activated.platelets inhibited, Blood | Temps de coagulation (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle | ||||||
|
|
S wave Amp L-AVF | amplitud de la onda S.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVF | |||||
|
|
Clot Formation Time FIBTEM | Clot formation.extrinsic coagulation system activated.platelets inhibited, Blood | Temps de formation du caillot (activation de la voie extrinsèque) avec inhibition des plaquettes [Temps] Sang ; Numérique ; Thromboélastographie rotationelle | ||||||
|
|
MELDNa score | ||||||||
|
|
DOP Penis ves W vasodilator IV |
|
|
||||||
| 100350-8 | Sesamum indicum 1 allergy test | Sésame (graine) 1 Ac IgE [Arbitraire/Volume] Sérum ; Numérique | Sesamum indicum 1 As.IgE [eenheid/volume] in serum | ||||||
| 100351-6 | Pioglitazone, Blood | Pioglitazone [Présence/Seuil] Sérum/Plasma ; Qualitatif | Pioglitazon [aanwezigheid] in serum of plasma |
|
|||||
| 100352-4 | Rosiglitazone, Blood | Rosiglitazone [Présence/Seuil] Sérum/Plasma ; Qualitatif | Rosiglitazon [aanwezigheid] in serum of plasma |
|
|||||
| 100353-2 | Norwalk Community Health Center Screening Tool [NCHC] | ||||||||
| 10035-4 |
|
amplitud de la onda S.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVL | |||||
| 100354-0 | Frequency of participating in multi-modal communication without assistance | ||||||||
| 100355-7 | Frequency of participating in spoken language expression communication without assistance | ||||||||
| 100356-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis, Specimen | Chlamydia trachomatis et Neisseria gonorrhoeae et Trichomonas vaginalis ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cible | Chlamydia trachomatis & Neisseria gonorrhoeae & Trichomonas vaginalis DNA [identificator] d.m.v. probe-detectie | ||||||
| 100357-3 |
|
Naloxone [Présence/Seuil] Tissu de cordon ; Qualitatif ; Dépistage | Naloxon [aanwezigheid] in weefsel van navelstreng d.m.v. screening | ||||||
| 100358-1 |
|
Phentermine [Présence/Seuil] Tissu de cordon ; Qualitatif ; Dépistage | Fentermine [aanwezigheid] in weefsel van navelstreng d.m.v. screening | ||||||
| 100359-9 | Gliadin 33 mer peptide, Stool | Gliadine 33-mer peptide [Masse/Volume] Selle ; Numérique ; Immunoanalyse | Gliadin 33-mer peptide [massa/volume] in feces d.m.v. immunoassay | ||||||
|
|
Brief Resilience Scale panel [BRS] |
|
|
||||||
|
|
Quickly recover from bad events | ||||||||
|
|
S wave Amp L-AVR | amplitud de la onda S.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conducir AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-AVR | |||||
| 100362-3 | Difficulty making it through stressful events | ||||||||
| 100363-1 | Easily recover from a stressful event | ||||||||
| 100364-9 | Difficulty recovering from bad events | ||||||||
| 100365-6 | Easily recover from difficulties | ||||||||
| 100366-4 | Lengthy recovery from setbacks | ||||||||
| 100367-2 | Total Score BRS | ||||||||
| 100368-0 | Amino Acids Urea Cycle Panel, Blood | Acides aminés du cycle de l'urée panel [-] Sérum/Plasma ; - ; LC/MS/MS | Aminozuren ureumcyclus panel in serum of plasma d.m.v. LC/MS/MS | ||||||
| 100369-8 | NM Thyroid Views W Tl-201 IV | ||||||||
| 10037-0 | S wave Amp L-I | amplitud de la onda S.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100370-6 | Orthopoxvirus DNA [Nachweis oder Identität] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus, Specimen |
|
Orthopoxvirus ADN [Identification] Milieux divers ; Résultat nominal ; PCR amplification de cible |
|
||||
| 100371-4 |
|
Titine anticorps [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | |||||||
| 100372-2 | Abiraterone, Blood | Abiratérone [Masse/Volume] Sérum/Plasma ; Numérique | Abirateron [massa/volume] in serum of plasma | ||||||
| 100373-0 | Agar- agar IgG antibody | Eucheuma Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Eucheuma As.IgG [eenheid/volume] in serum | ||||||
| 100374-8 |
|
|
Aloe vera Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Aloë vera As.IgG [eenheid/volume] in serum | |||||
| 100375-5 |
|
|
|
||||||
| 100376-3 | Bambusa vulgaris IgG antibody | Bambou commun Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Bambusa vulgaris As.IgG [eenheid/volume] in serum | ||||||
| 100377-1 | Goat cheese IgG antibody | Fromage de chèvre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Geitenkaas As.IgG [eenheid/volume] in serum | ||||||
| 100378-9 | Sheep cheese IgG antibody | Fromage de brebis Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Schapenkaas As.IgG [eenheid/volume] in serum | ||||||
| 100379-7 |
|
Poireau vivace Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Allium ampeloprasum As.IgG [eenheid/volume] in serum |
|
|||||
| 100380-5 | Red cabbage IgG antibody | Chou rouge Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica rubra As.IgG [eenheid/volume] in serum | ||||||
| 100381-3 | Mentha balsamea Wild IgG antibody | Menthe poivrée hybride Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Pepermunt As.IgG [eenheid/volume] in serum | ||||||
| 100382-1 | FDA insert REMS addressed risk | ||||||||
| 100383-9 | Affenpockenvirus-DNA ql. /Sondermaterial PCR | Affenpocken-Virus DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus, Specimen | Monkeypox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Mpoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||
| 100384-7 |
|
|
|
|
|||||
| 100385-4 | Corn salad IgG antibody | Mâche Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Valerianella locusta As.IgG [eenheid/volume] in serum | ||||||
| 100386-2 |
|
|
|
|
|||||
| 100387-0 |
|
|
|
||||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
| 100390-4 |
|
|
|
|
|||||
| 100391-2 |
|
|
|
||||||
| 100392-0 |
|
|
|
||||||
| 100393-8 | Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG antibody | Allergène de champigons macroscopiques mix2 (Xerocomus, Boletus) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Paddenstoelallergenen mix 2 (Xerocomus + Boletus) As.IgG [eenheid/volume] in serum | ||||||
| 100394-6 | Decapod crustaceans IgG antibody | Astacoidea Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Astacoidea As.IgG [eenheid/volume] in serum | ||||||
| 100395-3 |
|
|
|
||||||
|
|
S wave Amp L-III | amplitud de la onda S.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-III | |||||
|
|
Brassica napus IgG antibody | Colza Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica napus As.IgG [eenheid/volume] in serum | ||||||
|
|
|
|
|
|
|||||
|
|
Goose meat IgG antibody | Oie (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Ganzenvlees As.IgG [eenheid/volume] in serum | ||||||
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||||
|
|
|
|
Lapin (viande) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Konijnenvlees As.IgG [eenheid/volume] in serum | |||||
|
|
|
|
|
|
|||||
|
|
Guineafowl IgG antibody | Pintade Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Parelhoen As.IgG [eenheid/volume] in serum | ||||||
|
|
S wave Amp L-V1 | amplitud de la onda S.derivación V1:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V1 | |||||
| 100404-3 |
|
|
|
||||||
| 100405-0 | Kefir IgG antibody | Kefir Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Kefir As.IgG [eenheid/volume] in serum | ||||||
| 100406-8 | Butter IgG antibody | Beurre Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Boter As.IgG [eenheid/volume] in serum | ||||||
| 100407-6 | Camembert cheese IgG antibody | Fromage camembert Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Camembert As.IgG [eenheid/volume] in serum | ||||||
| 100408-4 | Emmental cheese IgG antibody | Fromage emmental Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Emmentaler kaas As.IgG [eenheid/volume] in serum | ||||||
| 100409-2 | Processed cheese IgG antibody | Fromage fondu Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Smeltkaas As.IgG [eenheid/volume] in serum | ||||||
|
|
Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de complemento:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: |
|
Test direct à l'antiglobuline (EDA) complément spécifique [Présence/Seuil] Érythrocytes ; Qualitatif |
|
|
|||
| 100410-0 | Curd cheese IgG antibody | Fromage blanc Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Kwark As.IgG [eenheid/volume] in serum | ||||||
| 100411-8 |
|
|
|
|
|||||
| 10041-2 |
|
|
Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
|
|||||
| 100412-6 | Chinese cabbage IgG antibody | Chou chinois Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Chinese kool As.IgG [eenheid/volume] in serum | ||||||
| 100413-4 |
|
|
Fenouil Ac IgG [Arbitraire/Volume] Sérum ; Numérique |
|
|
||||
| 100414-2 | Gourd IgG antibody | Cucurbitaceae Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Genera in Cucurbitaceae As.IgG [eenheid/volume] in serum | ||||||
| 100415-9 | Kale IgG antibody | Chou frisé Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Brassica oleracea var. Borecole As.IgG [eenheid/volume] in serum | ||||||
| 100416-7 | Savoy cabbage IgG antibody | Chou de Milan [Arbitraire/Volume] Sérum ; Numérique | Brassica oleracea var. Sabauda As.IgG [eenheid/volume] in serum | ||||||
| 100417-5 | Vitis sp leaf IgG antibody | Feuille de vigne Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Blad van Vitis sp. As.IgG [eenheid/volume] in serum | ||||||
| 100418-3 | Liquorice IgG antibody | Réglisse Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Glycyrrhiza glabra As.IgG [eenheid/volume] in serum | ||||||
| 100419-1 | Snow pea IgG antibody | Pois gourmand Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Pisum sativum var. saccharatum As.IgG [eenheid/volume] in serum | ||||||
| 10042-0 | S wave Amp L-V3 | amplitud de la onda S.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100420-9 |
|
|
|
||||||
| 100421-7 |
|
|
|
|
|||||
| 100422-5 |
|
|
|
||||||
| 100423-3 | Button + oyster + Shiitaki + chanterelle mushroom IgG antibody | (Champignon de Paris+pleurote+lentin du chêne+catharelle) Ac IgG [Arbitraire/Volume] Sérum ; Numérique | Paddenstoelallergenen mix 1 (Agaricus bisporus + Pleurotus ostreatus + Lentinula edodes + Cantharellus) As.IgG [eenheid/volume] in serum | ||||||
| 100424-1 | 8(9)-Cholestenol, Blood | 8(9)-cholesténol [Masse/Volume] Sérum/Plasma ; Numérique | 8(9)-cholestenol [massa/volume] in serum of plasma | ||||||
| 100425-8 | DiHydro T-Mas, Blood | Dihydro T-Mas [Masse/Volume] Sérum/Plasma ; Numérique | DiHydro T-Mas [massa/volume] in serum of plasma | ||||||
| 100426-6 | Squalene, Blood | Squalène [Masse/Volume] Sérum/Plasma ; Numérique | |||||||
| 100427-4 |
|
Stigmastérol [Masse/Volume] Sérum/Plasma ; Numérique |
|
||||||
| 100428-2 |
|
Carnitine libre et totale et acylcarnitine panel [-] Urine ; - | Carnitine.vrij & totaal & acylcarnitine panel in urine | ||||||
| 100429-0 | LRBA deficiency panel, Blood | Déficience protéine LRBA panel [-] Sang ; - | LRBA-deficiëntie panel in bloed | ||||||
|
|
|
|
|
|
|||||
|
|
T-cells LRBA MFI, Blood | CD3+CD14-CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de flux | Cellen.CD3+CD14-CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | ||||||
|
|
Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+, Blood | LRBA+/100 cellules CD3-CD14-CD19+CD45+ [Fraction de nombres] Sang ; Numérique ; Cytométrie de flux | Cellen.LRBA+/100 cellen.CD3-CD14-CD19+CD45+ [getalsfractie] in bloed d.m.v. flowcytometrie | ||||||
|
|
B-cells LRBA MFI, Blood | CD3-CD14-CD19+CD45+LRBA intensité de fluorescence [Arbitraire] Sang ; Numérique ; Cytométrie de flux | Cellen.CD3-CD14-CD19+CD45+.LRBA gemiddelde fluorescentie-intensiteit [aanwezigheid] in bloed d.m.v. flowcytometrie | ||||||
|
|
Orthopoxvirus.nicht-variola DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Orthopoxvirus.non-variola, Specimen | Orthopoxvirus non variola ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Orthopoxvirus anders dan variolavirus DNA [aanwezigheid] d.m.v. probe-detectie | |||||
|
|
Glial fibrillary acidic protein, Blood | GFAP [Masse/Volume] Sérum ; Numérique ; Immunoanalyse | Gliaal fibrillair acidisch proteïne [massa/volume] in serum d.m.v. immunoassay | ||||||
|
|
|
|
Ubiquitin carboxyl-terminal hydrolase-L1 [Masse/Volume] Sérum ; Numérique ; Immunoanalyse |
|
|||||
|
|
|
Norsufentanil [Masse/Volume] Urine ; Numérique ; Confirmation | Norsufentanil [massa/volume] in urine d.m.v. bevestiging | ||||||
|
|
|
amplitud de la onda S.derivación V4:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V4:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V4 | |||||
| 100438-1 | Adolescent med OP Prog note | ||||||||
| 100439-9 | Allergy+Immunology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. allergie+immunologie (document) | ||||||
|
|
Allergy OP Prog note |
|
|
||||||
|
|
Attend OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. behandelend arts (document) | |||||||
|
|
Audiology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. audiologie (document) | ||||||
|
|
Bariatric surg OP Prog note |
|
|||||||
|
|
Bld Bnk+Trans Med OP Prog note | ||||||||
|
|
BM Transplant OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. beenmergtransplantatie (document) | |||||||
|
|
S wave Amp L-V5 |
|
|
S onda Amp L-V5 | |||||
| 100446-4 | Breastfeeding OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. borstvoeding (document) | ||||||
| 100447-2 | Burn OP Prog note | ||||||||
| 100448-0 | Cardiac surgery OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. cardiochirurgie (document) | ||||||
| 100449-8 | Cardio+Pulm dis OP Prog note | ||||||||
|
|
Child+teen psych OP Prog note |
|
|
||||||
|
|
Chiropractic med OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. chiropractie (document) | |||||||
|
|
Electrophysiology OP Prog note |
|
|||||||
|
|
S wave Amp L-V6 |
|
Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S onda Amp L-V6 | |||||
| 100453-0 | Clinical genetics OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. klinische genetica (document) | ||||||
| 100454-8 | Clinical Neurophys OP Prog note | ||||||||
| 100455-5 | Clin Path OP Prog note | ||||||||
| 100456-3 | Col+rec surg OP Prog note | ||||||||
| 100457-1 | Consultant OP Prog note | ||||||||
| 100458-9 | OP COVID-19 Intub+Progress | ||||||||
| 100459-7 | OP COVID-19 Progress note | ||||||||
|
|
Dermatology OP Prog note |
|
|
||||||
|
|
S wave dur L-AVF |
|
|
S onda dur L-AVF | |||||
| 100461-3 | Develop-behav peds OP Prog note | ||||||||
| 100462-1 | Dialy+Ther Apher OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. dialyse en therapeutische aferese (document) | ||||||
| 100463-9 | Eating disorders OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. eetstoornis (document) | ||||||
| 100464-7 | Endocrinology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. endocrinologie (document) | ||||||
| 100465-4 | Fam Med OP Prog note | ||||||||
| 100466-2 | Gastroenterology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. gastro-enterologie (document) | ||||||
| 100467-0 | Geri med OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. geriatrie (document) | ||||||
| 100468-8 | Gyn Onc OP Prog note | ||||||||
| 100469-6 | Gynecology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. gynaecologie (document) |
|
||||||
| 100470-4 | Navigator OP Prog note | ||||||||
| 100471-2 | Heart failure OP Prog note | ||||||||
| 100472-0 | HF+TC OP Prog note | ||||||||
| 100473-8 | Hematology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie (document) | ||||||
| 100474-6 | HemOnc OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. hematologie + oncologie (document) | ||||||
| 100475-3 | Hepatology OP Prog note | ||||||||
| 100476-1 | Immunology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. immunologie (document) | ||||||
| 100477-9 | Infectious disease OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. infectioloog (document) | ||||||
| 100478-7 | Internal Med OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. interne geneeskunde (document) | ||||||
|
|
S wave dur L-AVL |
|
Duración de la onda S. Plomo AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-AVL | |||||
|
|
IC OP Prog note |
|
|
||||||
| 100480-3 | IR OP Prog note | ||||||||
| 100481-1 | OP MCS+progress note | ||||||||
| 100482-9 | MAiD OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. medische zorg bij sterven (document) | ||||||
| 100483-7 | Mental health OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. geestelijke gezondheidszorg (document) | ||||||
| 100484-5 | Multi-spec prog OP Prog note | ||||||||
| 100485-2 | Neo peri med OP Prog note | ||||||||
| 100486-0 | Nephrology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. nefrologie (document) | ||||||
|
|
S wave dur L-AVR |
|
|
S onda dur L-AVR | |||||
|
|
Neuro surgery OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurochirurgie (document) | ||||||
|
|
Neurology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. neurologie (document) | |||||||
|
|
Child neuro OP Prog note |
|
|
||||||
| 100490-2 | Nurse pract OP Prog note | ||||||||
| 100491-0 | Nurse OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. verpleegkundige (document) | ||||||
| 100492-8 | Nutr+diet OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. voeding en diëtetiek (document) | ||||||
| 100493-6 | OBGYN OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie en gynaecologie (document) | ||||||
| 100494-4 | OB OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. obstetrie (document) | ||||||
|
|
S wave dur L-I |
|
|
S onda dur L-I | |||||
|
|
OT OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. bezigheidstherapie (document) | ||||||
|
|
Oncology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. oncologie (document) | ||||||
|
|
Ophthalmol OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. oogheelkunde (document) | ||||||
|
|
Optometry OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. optometrie (document) | ||||||
|
|
|
|
|
|
|
|
|||
|
|
Orthopaedic surgery OP Prog note |
|
|
||||||
|
|
Orthotics prosthetics OP Prog note |
|
|||||||
|
|
Otolaryngology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. KNO (document) | |||||||
|
|
S wave dur L-II |
|
|
S onda dur L-II | |||||
| 100503-2 | Pain medicine OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. pijnbestrijding (document) | ||||||
| 100504-0 | Palliative care OP Prog note | ||||||||
| 100505-7 | Peds cardiology OP Prog note | ||||||||
| 100506-5 | Peds dermatology OP Prog note | ||||||||
| 100507-3 | Peds endocrinology OP Prog note | ||||||||
| 100508-1 | Peds gastroenterology OP Prog note | ||||||||
| 100509-9 | Peds hem-onc OP Prog note | ||||||||
|
|
Peds infect disease OP Prog note |
|
|
||||||
|
|
S wave dur L-III |
|
Duración de la onda S. Plomo III:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-III | |||||
| 100511-5 | Peds otolaryngology OP Prog note | ||||||||
| 100512-3 | Peds pulmonology OP Prog note | ||||||||
| 100513-1 | Peds rheumatology OP Prog note | ||||||||
| 100514-9 | Peds surgery OP Prog note | ||||||||
| 100515-6 | Peds transpl hepato OP Prog note | ||||||||
| 100516-4 | Peds urology OP Prog note | ||||||||
| 100517-2 | Pharmacogenomics OP Prog note | ||||||||
| 100518-0 | PM+R OP Prog note | ||||||||
| 100519-8 | PT OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. fysiotherapie (document) | ||||||
|
|
Plastic surgery OP Prog note |
|
|
||||||
|
|
Podiatry OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. podologie (document) | ||||||
|
|
Psychiatric Hosp Prog note |
|
Voortgangsrapport [bevinding] in ziekenhuis d.m.v. psychiatrie (document) | ||||||
|
|
Psych OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychologie (document) | |||||||
|
|
Pulmonary disease OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. longaandoening (document) | ||||||
|
|
Radiation Onc OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiotherapie (document) | ||||||
|
|
Radiology OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. radiologie (document) | ||||||
|
|
Rec therapy OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. recreationele therapie (document) | ||||||
|
|
REI OP Prog note |
|
|||||||
|
|
S wave dur L-V1 | duración de la onda S.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
S onda dur L-V1 | |||||
| 100529-7 | Research OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. wetenschappelijk onderzoek (document) | ||||||
|
|
Rheumatology OP Prog note |
|
|
||||||
|
|
Sleep med OP Prog note |
|
|||||||
|
|
SW OP Prog note | ||||||||
|
|
Solid Org Transplant OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. transplantatie van solide orgaan (document) | |||||||
|
|
Speech-lang path OP Prog note |
|
|||||||
|
|
Spinal surgery OP Prog note | ||||||||
|
|
Sports medicine OP Prog note | ||||||||
|
|
S wave dur L-V2 |
|
Duración de la onda S. derivación V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V2 | |||||
| 100537-0 | Hand Surgery OP Prog note | ||||||||
| 100538-8 | Telehealth+Outpatient Prog note | ||||||||
| 100539-6 | Thromboemb OP Prog note | ||||||||
|
|
Transpl surg OP Prog note |
|
|
||||||
|
|
Trauma OP Prog note |
|
|||||||
|
|
Urology OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. urologie (document) | |||||||
|
|
Vasc Neuro OP Prog note |
|
|||||||
|
|
Vascular surgery OP Prog note | Voortgangsrapport [bevinding] in poliklinisch d.m.v. vaatchirurgie (document) | |||||||
|
|
S wave dur L-V3 |
|
|
S onda dur L-V3 | |||||
| 100545-3 | Wound care management OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. wondzorg (document) | ||||||
| 100546-1 | WOC OP Prog note | ||||||||
| 100547-9 | Adolescent med Hosp Prog note | ||||||||
| 100548-7 | Allergy+Immunology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. allergie+immunologie (document) | |||||||
| 100549-5 | Allergy Hosp Prog note | ||||||||
|
|
Attend Hosp Prog note |
|
|
||||||
|
|
Audiology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. audiologie (document) | |||||||
|
|
S wave dur L-V4 | duración de la onda S.derivación V4:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V4:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V4 | |||||
| 100552-9 | Bariatric surg Hosp Prog note | ||||||||
| 100553-7 | Bld Bnk+Trans Med Hosp Prog note | ||||||||
| 100554-5 | BM Transplant Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. beenmergtransplantatie (document) | |||||||
| 100555-2 | Breastfeeding Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. borstvoeding (document) | |||||||
| 100556-0 | Burn Hosp Prog note | ||||||||
| 100557-8 | Cardiac surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. cardiochirurgie (document) | |||||||
| 100558-6 | Cardio+Pulm dis Hosp Prog note | ||||||||
| 100559-4 | Child+teen psych Hosp Prog note | ||||||||
| 10056-0 | S wave dur L-V5 | duración de la onda S.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100560-2 | Electrophysiology Hosp Prog note | ||||||||
| 100561-0 | Clinical genetics Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. klinische genetica (document) | |||||||
| 100562-8 | Clinical Neurophys Hosp Prog note | ||||||||
| 100563-6 | Clin Path Hosp Prog note | ||||||||
| 100564-4 | Col+rec surg Hosp Prog note | ||||||||
| 100565-1 | Consultant Hosp Prog note | ||||||||
| 100566-9 | Dentistry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. tandheelkunde (document) | |||||||
| 100567-7 | Dermatology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dermatologie (document) | |||||||
| 100568-5 | Develop-behav peds Hosp Prog note | ||||||||
| 100569-3 | Dialy+Ther Apher Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. dialyse en therapeutische aferese (document) | |||||||
|
|
Eating disorders Hosp Prog note |
|
|
||||||
|
|
Endocrinology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. endocrinologie (document) | |||||||
|
|
Fam Med Hosp Prog note |
|
|||||||
|
|
Gastroenterology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gastro-enterologie (document) | |||||||
|
|
General medicine Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. algemene geneeskunde (document) | |||||||
|
|
Geri med Hosp Prog note |
|
Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geriatrie (document) | ||||||
|
|
Gyn Onc Hosp Prog note | ||||||||
|
|
Gynecology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. gynaecologie (document) | |||||||
|
|
S wave dur L-V6 | duración de la onda S.derivación V6:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S onda dur L-V6 | |||||
| 100578-4 | Navigator Hosp Prog note | ||||||||
| 100579-2 | Heart failure Hosp Prog note | ||||||||
|
|
Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo específico de IgG [Inmunoglobulina G]:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: |
|
Test indirect à l'antiglobuline (TIA) IgG spécifique [Présence/Seuil] Sérum/Plasma ; Qualitatif |
|
|
|||
| 100580-0 | HF+TC Hosp Prog note | ||||||||
| 100581-8 | Hematology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie (document) | |||||||
| 100582-6 | HemOnc Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. hematologie + oncologie (document) | |||||||
| 100583-4 | Hepatology Hosp Prog note | ||||||||
| 100584-2 | Immunology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. immunologie (document) | |||||||
| 100585-9 | Infectious disease Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. infectioloog (document) | |||||||
|
|
S' wave Amp L-AVF |
|
|
S' onda Amp L-AVF | |||||
|
|
Internal Med Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. interne geneeskunde (document) | |||||||
|
|
IC Hosp Prog note | ||||||||
|
|
IR Hosp Prog note | ||||||||
|
|
Hosp MCS+progress note |
|
|
||||||
| 100590-9 | MAiD Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. medische zorg bij sterven (document) | |||||||
| 100591-7 | Mental health Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. geestelijke gezondheidszorg (document) | |||||||
| 100592-5 | Multi-spec prog Hosp Prog note | ||||||||
| 100593-3 | Neo peri med Hosp Prog note | ||||||||
|
|
S' wave Amp L-AVL | amplitud de la onda S'.derivación AVL:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. Conduzca AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-AVL | |||||
|
|
Nephrology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. nefrologie (document) | |||||||
|
|
Neuro surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurochirurgie (document) | |||||||
|
|
Neurology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. neurologie (document) | |||||||
|
|
Child neuro Hosp Prog note | ||||||||
|
|
Nurse pract Hosp Prog note | ||||||||
|
|
Nurse Hosp Prog note |
|
|
|
|
|
|||
|
|
Nutr+diet Hosp Prog note |
|
|
||||||
|
|
OBGYN Hosp Prog note |
|
Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie en gynaecologie (document) | ||||||
|
|
S' wave Amp L-AVR |
|
|
S' onda Amp L-AVR | |||||
| 100602-2 | OB Hosp Prog note |
|
Voortgangsrapport [bevinding] in ziekenhuis d.m.v. obstetrie (document) | ||||||
| 100603-0 | OT Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. bezigheidstherapie (document) | |||||||
| 100604-8 | Oncology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oncologie (document) | |||||||
| 100605-5 | Ophthalmol Hosp Prog note |
|
Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oogheelkunde (document) | ||||||
| 100606-3 | OMS Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. oromaxillofaciale chirurgie (document) | |||||||
| 100607-1 | Orthopaedic surgery Hosp Prog note |
|
Voortgangsrapport [bevinding] in ziekenhuis d.m.v. orthopedische chirurgie (document) | ||||||
| 100608-9 | Orthotics prosthetics Hosp Prog note | ||||||||
| 100609-7 | Otolaryngology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. KNO (document) | |||||||
| 10061-0 | S' wave Amp L-I | amplitud de la onda S'.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100610-5 | Pain medicine Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. pijnbestrijding (document) | |||||||
| 100611-3 | Palliative care Hosp Prog note | ||||||||
| 100612-1 | Pastoral Care Hosp Prog note | ||||||||
| 100613-9 | Peds cardiology Hosp Prog note | ||||||||
| 100614-7 | Peds dermatology Hosp Prog note | ||||||||
| 100615-4 | Peds endocrinology Hosp Prog note | ||||||||
| 100616-2 | Peds gastroenterology Hosp Prog note | ||||||||
| 100617-0 | Peds hem-onc Hosp Prog note | ||||||||
| 100618-8 | Peds infect disease Hosp Prog note | ||||||||
| 100619-6 | Peds otolaryngology Hosp Prog note | ||||||||
|
|
Peds pulmonology Hosp Prog note |
|
|
||||||
|
|
Peds rheumatology Hosp Prog note | ||||||||
|
|
Peds surgery Hosp Prog note | ||||||||
|
|
Peds transpl hepato Hosp Prog note | ||||||||
|
|
Pharmacogenomics Hosp Prog note | ||||||||
|
|
Pharmacology Hosp Prog note | ||||||||
|
|
PM+R Hosp Prog note | ||||||||
|
|
PT Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. fysiotherapie (document) | |||||||
|
|
S' wave Amp L-II | amplitud de la onda S'.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-II | |||||
| 100628-7 | Plastic surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. plastische chirurgie (document) | |||||||
| 100629-5 | Podiatry Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. podologie (document) | |||||||
|
|
Psych Hosp Prog note |
|
|
||||||
|
|
Radiation Onc Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiotherapie (document) | |||||||
|
|
Radiology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. radiologie (document) | |||||||
|
|
Rapid response team Hosp Prog note | ||||||||
|
|
Rec therapy Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. recreationele therapie (document) | |||||||
|
|
REI Hosp Prog note | ||||||||
|
|
S' wave Amp L-III |
|
Amplitud de onda S. derivación III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-III | |||||
| 100636-0 | Research Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wetenschappelijk onderzoek (document) | |||||||
| 100637-8 | Rheumatology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. reumatologie (document) | |||||||
| 100638-6 | Sleep med Hosp Prog note | ||||||||
| 100639-4 | SW Hosp Prog note | ||||||||
|
|
Solid Org Transplant Hosp Prog note |
|
|
||||||
|
|
Speech-lang path Hosp Prog note | ||||||||
|
|
Spinal surgery Hosp Prog note | ||||||||
|
|
Hand Surgery Hosp Prog note | ||||||||
|
|
S' wave Amp L-V1 |
|
Amplitud de onda S. derivación V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V1 | |||||
| 100644-4 | Thromboemb Hosp Prog note | ||||||||
| 100645-1 | Trauma Hosp Prog note | ||||||||
| 100646-9 | Urology Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. urologie (document) | |||||||
| 100647-7 | Vasc Neuro Hosp Prog note | ||||||||
| 100648-5 | Vascular surgery Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. vaatchirurgie (document) | |||||||
| 100649-3 | Wound care management Hosp Prog note | Voortgangsrapport [bevinding] in ziekenhuis d.m.v. wondzorg (document) | |||||||
|
|
WOC Hosp Prog note |
|
|
||||||
|
|
S' wave Amp L-V2 |
|
Amplitud de onda S. derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V2 | |||||
| 100651-9 | Hosp COVID-19 Intub+Progress | ||||||||
| 100652-7 | Pure tone bone thresh Pnl | ||||||||
| 100653-5 | Pure tone air thresh Pnl | ||||||||
| 100654-3 | M2-PK (Pyruvatkinase) /Stuhl | Pyruvatkinase M2 [Nachweis] in Stuhl | Pyruvate kinase M2, Stool | Pyruvate kinase M2 [Présence/Seuil] Selle ; Qualitatif | Pyruvaatkinase M2 [aanwezigheid] in feces | ||||
| 100655-0 | XR ST Lat |
|
|||||||
| 100656-8 | Mat fetal med OP Prog note | ||||||||
| 100657-6 | Mat fetal med Phone+Hosp Prog note | ||||||||
| 100658-4 | Hosp COVID-19 Progress note | ||||||||
| 100659-2 | Mat fetal med Hosp Prog note | ||||||||
|
|
Direkter Antiglobulintest.IgG-spezifisches Reagenz [Interpretation] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo específico de IgG [Inmunoglobulina G]:impresión/interpretación del estudio:punto en el tiempo:eritrocitos:Nominal: |
|
Test direct à l'antiglobuline (EDA) IgG spécifique [Interprétation] Érythrocytes ; Résultat nominal |
|
|
||
| 100660-0 | Mat fetal med Phone+OP Prog note | ||||||||
| 100661-8 | Psychiatric OP Prog note |
|
Voortgangsrapport [bevinding] in poliklinisch d.m.v. psychiatrie (document) | ||||||
| 100662-6 | Cortisol free and total panel, Blood | Cortisol libre et total panel [-] Sérum/Plasma ; - | Cortisol vrij & totaal panel in serum of plasma | ||||||
| 100663-4 | TPMT gene c.460G>A&c.719A>G, Blood | TPMT gène c.460G>A et c.719A>G [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | TPMT-gen c.460G>A&c.719A>G [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | ||||||
| 100664-2 | NUDT15 gene c.50_55dup&c.415C>T, Blood | NUDT15 gène c.50_55dup et c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.50_55dup&c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | ||||||
| 100665-9 | NUDT15 gene c.415C>T, Blood | NUDT15 gène c.415C>T [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.415C>T [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | ||||||
| 100666-7 | NUDT15 gene c.52G>A, Blood | NUDT15 gène c.416G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.416G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | ||||||
| 100667-5 | NUDT15 gene c.52G>A, Blood | NUDT15 gène c.52G>A [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.52G>A [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | ||||||
| 100668-3 | NUDT15 gene c.50_55dup, Blood | NUDT15 gène c.50_55dup [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | NUDT15-gen c.50_55dup [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | ||||||
|
|
S' wave Amp L-V3 | amplitud de la onda S'.derivación V3:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | Amplitud de onda S. derivación V3:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V3 | |||||
|
|
|
|
|
|
|||||
| 100670-9 | Fetal RHD gene allele--fetus | RHD gène allèle du fœtus [Identification] Plasma avec ADN libre circulant ; Résultat nominal | RHD-allel^foetus [identificator] in plasma.celvrij DNA | ||||||
| 100671-7 | Aspergillus sp, Blood |
|
Aspergillus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible | Aspergillus sp. DNA [aanwezigheid] in bloed d.m.v. probe-detectie |
|
||||
| 100672-5 | Aspergillus fumigatus, Blood |
|
Aspergillus fumigatus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible |
|
|
||||
| 100673-3 |
|
|
Aspergillus terreus ADN [Présence/Seuil] Sang ; Qualitatif ; PCR amplification de cible |
|
|
||||
| 100674-1 |
|
|
BK virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible |
|
|||||
| 100675-8 | Cytomegalie-Virus DNA [Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion |
|
|
Cytomégalovirus ADN [Arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible |
|
||||
| 100676-6 | Cytomegalie-Virus DNA [log Einheiten/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion |
|
|
Cytomégalovirus ADN [Log arbitraire/Volume] Sang ; Numérique ; PCR amplification de cible |
|
||||
|
|
S' wave Amp L-V4 |
|
|
S' onda Amp L-V4 | |||||
|
|
|
|
Epstein barr virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible |
|
|||||
|
|
|
|
Epstein barr virus ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible |
|
|||||
|
|
|
|
|
|
|||||
| 100680-8 | Herpes virus (HHV) 6, Blood |
|
Herpes virus 6 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible |
|
|||||
| 100681-6 | Herpes virus (HHV) 7, Blood |
|
Herpes virus 7 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible |
|
|||||
| 100682-4 | Herpes virus (HHV) 7, Blood |
|
Herpes virus 7 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible |
|
|||||
| 100683-2 |
|
|
Herpes virus 8 ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible |
|
|||||
| 100684-0 |
|
|
Herpes virus 8 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible |
|
|||||
|
|
S' wave Amp L-V5 |
|
|
|
|||||
|
|
|
|
JC virus ADN [Log Nombre/Volume] Sérum/Plasma ; Numérique ; PCR amplification de cible |
|
|||||
|
|
|
|
JC virus ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible |
|
|||||
|
|
JC virus, Urine |
|
JC virus ADN [Log Nombre/Volume] Urine ; Numérique ; PCR amplification de cible |
|
|||||
|
|
Parvovirus B19 DNA [log #/Volumen] (Viruslast) in Blut mittels Nukleinsäureamplifikation mit Sondendetektion | Parvovirus B19, Blood |
|
Parvovirus B19 ADN [Log Nombre/Volume] Sang ; Numérique ; PCR amplification de cible |
|
||||
|
|
Toxoplasma gondii DNA [log #/Volumen] in Serum oder Plasma mittels Nukleinsäureamplifikation mit Sondendetektion |
|
|
|
|
||||
| 100690-7 | Toxoplasma gondii DNA [log #/Volumen] in Liquor mittels Nukleinsäureamplifikation mit Sondendetektion | Toxoplasma gondii, Spinal fluid |
|
Toxoplasma gondii ADN [Log Nombre/Volume] Liquide céphalorachidien ; Numérique ; PCR amplification de cible |
|
||||
| 100691-5 |
|
|
|
Varicella-zostervirus DNA [logaritmisch aantal/volume] in bloed d.m.v. probe-detectie | |||||
| 100692-3 |
|
|
|
Varicella-zostervirus DNA [logaritmisch aantal/volume] in liquor cerebrospinalis d.m.v. probe-detectie | |||||
|
|
|
|
Amplitud de onda S. derivación V6:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | S' onda Amp L-V6 | |||||
|
|
Pneumocystis jirovecii, Respiratory system specimen | Pneumocystis jiroveci ADN [Log Nombre/Volume] Échantillon du système respiratoire ; Numérique ; PCR amplification de cible | Pneumocystis jiroveci DNA [logaritmisch aantal/volume] in respiratoir monster d.m.v. probe-detectie | ||||||
|
|
|
SMN1 gène analyse des porteurs silencieux [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaire |
|
||||||
|
|
Genetic disease analysis overall carrier interpretation, Blood or tissue specimen | Maladie génétique transmise interprétation globale [Interprétation] Sang/Tissu ; Résultat textuel ; Biologie moléculaire | |||||||
|
|
CTNS related multigene analysis, Body Fld+S/P | Analyse multigénique en relation avec le CTNS [Identification] Liquide biologique+Sérum/Plasma ; Résultat nominal ; Biologie moléculaire | CTNS-gerelateerde multigen-analyse [identificator] in lichaamsvloeistof en serum of plasma d.m.v. moleculair genetisch onderzoek | ||||||
|
|
IR OP Note | ||||||||
|
|
|
||||||||
|
|
Rifabutin/Ethambutol-Empfindlichkeit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
| 100701-2 |
|
|
Trichomonas vaginalis ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible |
|
|
||||
| 100702-0 | Mycoplasma genitalium rRNA [Nachweis] in Harnröhre mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urethra |
|
Mycoplasma genitalium ARNr [Présence/Seuil] Urètre ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in urethra d.m.v. probe-detectie |
|
|||
| 100703-8 | Mycoplasma genitalium rRNA [Nachweis] in Urin mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Urine |
|
Mycoplasma genitalium ARNr [Présence/Seuil] Urine ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in urine d.m.v. probe-detectie |
|
|||
| 100704-6 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial vom Gebärmutterhals mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Cervix |
|
Mycoplasma genitalium ARNr [Présence/Seuil] Col de l'utérus ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in cervix d.m.v. probe-detectie |
|
|||
| 100705-3 | Mycoplasma genitalium rRNA [Nachweis] in anorektalem Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Anorectal |
|
Mycoplasma genitalium ARNr [Présence/Seuil] Anorectal ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] in anorectaal d.m.v. probe-detectie | ||||
| 100706-1 | Mycoplasma genitalium rRNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Mycoplasma genitalium, Specimen |
|
Mycoplasma genitalium ARNr [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Mycoplasma genitalium rRNA [aanwezigheid] d.m.v. probe-detectie |
|
|||
| 100707-9 |
|
|
Cellules polymorphonucléaires [Nombre/Volume] Liquide de dialyse péritonéale ; Numérique ; Comptage automate |
|
|||||
| 100708-7 |
|
|
|
||||||
| 100709-5 | Hepatocellular carcinoma risk | Risque de cancer hépatocellulaire [Score] Patient ; Numérique ; GAAD | Risico op hepatocellulair carcinoom [score] d.m.v. GAAD-score | ||||||
|
|
|
Chlamydia trachomatis and Neisseria gonorrhoeae panel, Throat |
Chlamydia
trachomatis
|
Chlamydia
trachomatis
|
|||||
| 100711-1 | Borrelia burgdorferi.VlsE1+pepC10 Antikörper [Einheiten/Volumen] in Serum mittels Immunoassay | Borrelia burgdorferi.VlsE1+pepC10 antibody, Blood | Borrelia burgdorferi VlsE1+pepC10 Ac [Arbitraire/Volume] Sérum ; Numérique ; Immunoanalyse | Borrelia burgdorferi.VlsE1+pepC10 As [eenheid/volume] in serum d.m.v. immunoassay | |||||
| 100712-9 | Brexpiprazol |
|
Brexpiprazole [Masse/Volume] Sérum/Plasma ; Numérique | Brexpiprazol [massa/volume] in serum of plasma | |||||
| 100713-7 | Cariprazin |
|
Cariprazine [Masse/Volume] Sérum/Plasma ; Numérique | Cariprazine [massa/volume] in serum of plasma | |||||
| 100714-5 | Guanfacin | Guanfacine, Blood | Guanfacine [Masse/Volume] Sérum/Plasma ; Numérique | Guanfacine [massa/volume] in serum of plasma | |||||
| 100715-2 | Prothipendyl | Prothipendyl, Blood | Prothipendyl [Masse/Volume] Sérum/Plasma ; Numérique | Prothipendyl [massa/volume] in serum of plasma | |||||
| 100716-0 | Prostate specific antigen, Dried blood spot |
|
|
Prostate spécifique antigène [Masse/Volume] Sang buvard ; Numérique |
|
|
|||
| 100717-8 | FCGR3A gene.p.Phe176Val, Blood or tissue specimen | FCGR3A gène p.Phe176Val [Présence/Seuil] Sang/Tissu ; Qualitatif ; Biologie moléculaire | FCGR3A-gen.p.Phe176Val [aanwezigheid] in bloed of weefsel d.m.v. moleculair genetisch onderzoek | ||||||
| 100718-6 | Undersea+hyperbar D/C sum | ||||||||
|
|
S' wave dur L-AVL |
|
Duración de la onda S. Liderar AVL:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-AVL | |||||
|
|
Surg Onc D/C sum |
|
|
||||||
| 100720-2 | REI D/C sum | ||||||||
| 100721-0 | Comm hlth care D/C sum | ||||||||
| 100722-8 | Integrative medicine D/C sum | ||||||||
| 100723-6 | Sports medicine D/C sum | ||||||||
| 100724-4 | Diabetology D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. diabetologie (document) | |||||||
| 100725-1 | Optometry D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. optometrie (document) | |||||||
| 100726-9 | Podiatry D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. podologie (document) | |||||||
|
|
S' wave dur L-AVR |
|
|
S' onda dur L-AVR | |||||
|
|
Chiropractic med D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. chiropractie (document) | |||||||
|
|
Cardiac surgery D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. cardiochirurgie (document) | |||||||
|
|
Breastfeeding D/C sum |
|
|
||||||
| 100730-1 | Transpl surg D/C sum | Samenvattende ontslagbrief [bevinding] in {instelling} d.m.v. transplantatiechirurgie (document) | |||||||
| 100731-9 | Urgent care D/C sum | ||||||||
| 100732-7 | Cholesterol.in lipoprotein (little a) & Cholesterol.in LDL panel, Blood | Cholesterol Lp(a) et cholesterol LDL panel [-] Sérum ; - | Cholesterol.in lipoproteïne (kleine a) & cholesterol.in LDL panel in serum | ||||||
| 100733-5 | LDL cholesterol corrected for Cholesterol.in lipoprotein (little a), Blood | Cholestérol LDL corrigé par cholestérol Lp(a) [Masse/Volume] Sérum ; Numérique ; Résultat calculé | Cholesterol.in LDL^gecorrigeerd voor cholesterol.in lipoproteïne (kleine a) [massa/volume] in serum d.m.v. berekend | ||||||
| 100734-3 | traMADol and Metabolites Panel, Urine | Tramadol et métabolites panel [-] Urine ; - ; Confirmation | Tramadol & metabolieten panel in urine d.m.v. bevestiging | ||||||
| 10073-5 |
|
duración de la onda S'.derivación I:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S.:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-I | |||||
| 100735-0 | Mannose-6-phosphate isomerase and phosphomannomutase 1 panel, White blood cells |
|
Mannose-6-fosfaatisomerase & fosfomannomutase 1 panel in leukocyten | ||||||
| 100736-8 | Acylcarnitine Analysis Post Mortem, Specimen | Acylcarnitine post-mortem [Recherche] Milieux divers ; Document | Acylcarnitine postmortale analyse [bevinding] (document) | ||||||
| 100737-6 | Alkaline phosphatase.macromolecular, Blood | Phosphatase alcaline macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Alkalinefosfatase.macromoleculair [aanwezigheid] in serum of plasma | ||||||
| 100738-4 | Macromolecular alanine aminotransferase, Blood |
|
|
Alanine aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif |
|
|
|||
| 100739-2 |
|
|
Aspartate aminotransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif |
|
|
||||
|
|
Direkter Coombs Test polyspezifisch | Direkter Antiglobulintest.polyspezifisches Reagenz [Nachweis] auf Erythrozyten | Direct Antiglobulin Test (DAT; Direct Coombs), Red blood cells | prueba de antiglobulina directa.reactivo poliespecífico:concentración arbitraria:punto en el tiempo:eritrocitos:ordinal: |
|
Test direct à l'antiglobuline (EDA) polyvalente [Présence/Seuil] Érythrocytes ; Qualitatif |
|
|
|
| 100740-0 |
|
Amylase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Amylase.macromoleculair [aanwezigheid] in serum of plasma |
|
|||||
| 100741-8 | Gamma glutamyl transferase.macromolecular, Blood | Gamma glutamyltransférase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Gamma-glutamyltransferase.macromoleculair [aanwezigheid] in serum of plasma | ||||||
| 100742-6 | Lactate dehydrogenase.macromolecular, Blood | Lactate déhydrogénase macroenzyme [Présence/Seuil] Sérum/Plasma ; Qualitatif | Lactaatdehydrogenase.macromoleculair [aanwezigheid] in serum of plasma | ||||||
|
|
S' wave dur L-II | duración de la onda S'.derivación II:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo II:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-II | |||||
| 100743-4 |
|
| Lipase.macromoleculair [aanwezigheid] in serum of plasma | ||||||
|
|
Alpha-1-acid glycoprotein, Blood |
|
Alfa-1-zure glycoproteïne [massa/volume] in serum of plasma d.m.v. elektroforese | ||||||
| 100745-9 |
|
Chlorure [Moles/Volume] Sang mêlé veineux ; Numérique |
|
||||||
| 100746-7 |
|
Glucose [Moles/Volume] Sang mêlé veineux ; Numérique |
|
||||||
| 100747-5 | Legionella serogroup panel, Specimen | Legionella sérogroupe panel [-] Milieux divers ; - | Legionella serogroep panel | ||||||
| 100748-3 | Legionella spp [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella spp, Specimen | Legionella spp [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella spp. [aanwezigheid] d.m.v. probe-detectie | |||||
| 100749-1 | Legionella pneumophila, Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila serogroup 1, Specimen | Legionella pneumophila sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella pneumophila serogroep 1 [aanwezigheid] d.m.v. probe-detectie | |||||
| 10075-0 | S' wave dur L-III | duración de la onda S'.derivación III:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100750-9 | Legionella pneumophila, nicht Serogruppe 1 [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Legionella pneumophila non-serogroup 1, Specimen | Legionella pneumophila non sérogroupe 1 [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Legionella pneumophila anders dan serogroep 1 [aanwezigheid] d.m.v. probe-detectie | |||||
| 100751-7 | Galactose-alpha-1,3-galactose (Alpha-Gal) panel, Blood | Galactose-alpha-1,3-galactose panel [-] Sérum/Plasma ; - | Galactose-alfa-1,3-galactose panel in serum of plasma | ||||||
| 100752-5 | Exacerbating factors Reported | ||||||||
| 100753-3 | Alleviating factors Reported | ||||||||
| 100754-1 | Platelet disorders multigene analysis, Blood or tissue specimen | Analyse multigénique des troubles plaquettaires [Recherche] Sang/Tissu ; Document ; Séquençage | Trombocytopathie multigen-analyse [bevinding] in bloed of weefsel d.m.v. sequencing (document) | ||||||
| 100755-8 | Oligoclonal bands, Blood |
|
Eiwitfracties.oligoklonale banden [aantal] in serum of plasma d.m.v. iso-elektrisch focusseren | ||||||
| 100756-6 | Oligoclonal bands, Spinal fluid |
|
Protéines fractions oligoclonales [Interprétation] Liquide céphalorachidien ; Résultat nominal ; Isoélectrofocalisation | Eiwitfracties.oligoklonale banden [interpretatie] in liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | |||||
| 100757-4 | Protein fractions.oligoclonal bands panel, Serum+Cerebrospinal fluid | Protéines fractions oligoclonales panel [-] Sérum+Liquide céphalorachidien ; - ; Isoélectrofocalisation | Eiwitfracties.oligoklonale banden panel in serum en liquor cerebrospinalis d.m.v. iso-elektrisch focusseren | ||||||
| 100758-2 | Estimated lung age from clin data | ||||||||
| 100759-0 | Inspiratory reserve vol spirometry | ||||||||
|
|
XR Radius+Ulna-L 1V |
|
|
||||||
|
|
|
PALB2 gène mutation cible trouvée [Recherche] Sang/Tissu ; Document ; Biologie moléculaire |
|
|
|||||
|
|
HBA2 gene.c.377T>C, Blood |
|
HBA2 gène c.377T>C [Présence/Seuil] Sang ; Qualitatif ; Biologie moléculaire | HBA2-gen.c.377T>C [aanwezigheid] in bloed d.m.v. moleculair genetisch onderzoek | |||||
|
|
Mycobacterium sp comparative reaction interpretation, Skin | Comparatieve reactie op Mycobacterium sp. Interpretatie [interpretatie] in huid (tekstueel) | |||||||
|
|
Mycobacterium bovis reaction wheal 3 days after Mammalian Tuberculin Intradermal, Skin | Mycobacterium bovis huidreactie^3 dagen na dosis zoogdiertuberculine ID [diameter] in huid | |||||||
|
|
Homocysteine and Methylmalonate and Methylcitrate panel, Dried blood spot | Homocystéine et méthylmalonate et 2-méthylcitrate panel [-] Sang buvard ; - | Homocysteïne & methylmalonaat & 2-methylcitraat panel in gedroogde bloedspot | ||||||
|
|
Center for Epidemiologic Studies Depression Scale panel [CES-D] | ||||||||
|
|
Bothered by things that are not usually bothersome | ||||||||
|
|
S' wave dur L-V1 | duración de la onda S'.derivación V1:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V1:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V1 | |||||
| 100768-1 | Poor appetite | ||||||||
| 100769-9 | Unhappy even with help from my family or friends | ||||||||
|
|
Feeling just as good as others |
|
|
||||||
|
|
Trouble focusing | ||||||||
|
|
Feeling depressed | ||||||||
|
|
Feeling everything is too much of an effort | ||||||||
|
|
Feeling hopeful about the future | ||||||||
|
|
Feeling life had been a failure | ||||||||
|
|
S' wave dur L-V2 | duración de la onda S'.derivación V2:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V2:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V2 | |||||
| 100776-4 | Feeling fearful | ||||||||
| 100777-2 | Restless sleep | ||||||||
| 100778-0 | Feeling happy | ||||||||
| 100779-8 | Quieter than usual | ||||||||
|
|
Feeling lonely |
|
|
||||||
|
|
People were unfriendly | ||||||||
|
|
Enjoying life | ||||||||
|
|
Crying spells | ||||||||
|
|
S' wave dur L-V3 | duración de la onda S'.derivación V3:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma | Duración de la onda S. Plomo V3:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V3 | |||||
| 100784-8 | Feeling sad | ||||||||
| 100785-5 | Feeling people dislike me | ||||||||
| 100786-3 | Lack of energy | ||||||||
| 100787-1 | Total Score CES-D | ||||||||
| 100788-9 |
|
|
|
||||||
| 100789-7 |
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|||||
| 100792-1 | Forsythia allergy test | Forsythia Ac IgE [Arbitraire/Volume] Sérum ; Numérique | Forsythia As.IgE [eenheid/volume] in serum | ||||||
| 100793-9 |
|
Testostérone [Masse/Volume] Liquide biologique ; Numérique |
|
||||||
| 100794-7 |
|
Folliculostimuline [Arbitraire/Volume] Liquide biologique ; Numérique |
|
||||||
| 100795-4 |
|
Protéine S100B [Masse/Volume] Liquide biologique ; Numérique |
|
||||||
| 100796-2 |
|
|
Thyroglobuline [Masse/Volume] Liquide biologique ; Numérique |
|
|||||
| 100797-0 |
|
|
Testostérone libre T01 après épreuve [Masse/Volume] Sérum ; Numérique |
|
|||||
| 100798-8 |
|
Testostérone libre T02 après épreuve [Masse/Volume] Sérum ; Numérique |
|
||||||
| 100799-6 |
|
21-déoxycortisol T01 après épreuve [Masse/Volume] Sérum ; Numérique |
|
||||||
|
|
|
|
|
Cefoperazona: Aislado : Punto temporal: Susceptibilidad (microorganismos): Ordinal Cuantitativo: Concentración mínima inhibitoria (MIC) | Céfopérazone [Sensibilité] Isolat ; Alphanumérique ; CMI |
|
|
|
|
| 10080-0 | S' wave dur L-V5 | duración de la onda S'.derivación V5:tiempo:punto en el tiempo:corazón:cuantitativo:electrocardiograma |
|
|
|||||
| 100800-2 |
|
21-déoxycortisol T02 après épreuve [Masse/Volume] Sérum ; Numérique |
|
||||||
| 100801-0 |
|
|
21-déoxycortisol T03 après épreuve [Masse/Volume] Sérum ; Numérique |
|
|||||
| 100802-8 |
|
21-déoxycortisol T04 après épreuve [Masse/Volume] Sérum ; Numérique |
|
||||||
| 100803-6 |
|
21-déoxycortisol T05 après épreuve [Masse/Volume] Sérum ; Numérique |
|
||||||
| 100804-4 |
|
|
Vasopressine T01 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
| 100805-1 |
|
|
Vasopressine T02 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
| 100806-9 |
|
|
Vasopressine T03 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
| 100807-7 |
|
|
Vasopressine T04 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
| 100808-5 |
|
|
Vasopressine T05 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
| 100809-3 |
|
|
Vasopressine T06 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
|
|
|
|
|
|
|||||
|
|
|
|
Vasopressine T08 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
|
|
|
|
Vasopressine T09 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
|
|
|
|
Vasopressine T10 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
|
|
|
|
Vasopressine T11 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
|
|
|
|
Vasopressine T12 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
|
|
|
|
Glucagon T06 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique |
|
|||||
|
|
|
|
Glucagon T07 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique |
|
|||||
|
|
|
|
Duración de la onda S. Plomo V6:Corazón :Punto temporal:Tiempo:Cuantitativo:EKG | S' onda dur L-V6 | |||||
| 100818-4 |
|
|
Rénine T01 après épreuve [Masse/Volume] Plasma ; Numérique |
|
|||||
| 100819-2 |
|
|
Rénine T02 après épreuve [Masse/Volume] Plasma ; Numérique |
|
|||||
|
|
Indirekter Coombs Test polyspezifisch | Indirect Antiglobulin Test (IAT; Indirect Coombs), Blood | prueba de antiglobulina indirecta.reactivo multiespecífico:concentración arbitraria:punto en el tiempo:suero/plasma:ordinal: |
|
Test indirect à l'antiglobuline (TIA) polyvalente [Présence/Seuil] Sérum/Plasma ; Qualitatif |
|
|
||
| 100820-0 |
|
Rénine T03 après épreuve [Masse/Volume] Plasma ; Numérique |
|
||||||
| 100821-8 | POLST panel | ||||||||
| 100822-6 | Cardiopulmonary resuscitation orders | ||||||||
| 100823-4 | Initial portable medical treatment orders | ||||||||
| 100824-2 | Additional portable medical orders or instructions | ||||||||
| 100825-9 | Medically assisted nutrition orders | ||||||||
|
|
ST I-Amp 6ms L-AVF | amplitud inicial del segmento ST, 6 mseg.derivación AVF:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo AVF:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVF | |||||
|
|
Portable medical order &or advance directive review | ||||||||
|
|
Portable medical order discussion participants | ||||||||
|
|
|
|
|||||||
|
|
|
|
|
|
|||||
| 100830-9 |
|
|
Sous unité alpha libre T01 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique |
|
|||||
| 100831-7 |
|
|
Sous unité alpha libre T02 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique |
|
|||||
| 100832-5 |
|
|
Sous unité alpha libre T03 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique | Alfa-subeenheid.vrij^3de monster na XXX belasting [eenheid/volume] in serum of plasma | |||||
| 100833-3 |
|
Sous unité alpha libre T04 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique |
|
||||||
|
|
|
|
ST amplitud inicial 6 ms plomo AVL:Corazón :Punto temporal:Elpot:Cuantitativo:EKG |
|
|||||
|
|
|
|
Sous unité alpha libre T05 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique |
|
|||||
|
|
|
|
Sous unité alpha libre T06 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique |
|
|||||
|
|
|
|
Sous unité alpha libre T07 après épreuve [Arbitraire/Volume] Sérum/Plasma ; Numérique |
|
|||||
|
|
|
Insulin-like growth factor 1 T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique |
|
||||||
|
|
Testosterone 9th specimen after challenge, Blood | Testostérone T09 après épreuve [Masse/Volume] Sérum/Plasma ; Numérique | Testosteron^9de monster na XXX belasting [massa/volume] in serum of plasma | ||||||
|
|
|
|
|
|
|||||
| 100840-8 |
|
Immunoglobuline E [Arbitraire/Volume] Liquide biologique ; Numérique |
|
||||||
| 100841-6 |
|
|
Zic4 anticorps [Présence/Seuil] Liquide céphalorachidien ; Qualitatif ; Blot en ligne | Zinc finger proteïne of the cerebellum 4 As [aanwezigheid] in liquor cerebrospinalis d.m.v. lijnblot | |||||
|
|
ST I-Amp 6ms L-AVR | amplitud inicial del segmento ST, 6 mseg.derivación AVR:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms avance AVR:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-AVR | |||||
|
|
Nonalcoholic steatohepatitis score, Blood | Stéatohépatite non alcoolique - Score [Score] Sérum/Plasma ; Numérique ; Calculé FAST | |||||||
|
|
Liver fibrosis score, Blood | Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile3+ | |||||||
|
|
Liver fibrosis score, Blood | Score de fibrose hépatique [Score] Sérum/Plasma ; Numérique ; Calculé par Agile4 | |||||||
|
|
Neurofascin155 IgG4 antibody, Blood | Neurofascine155 Ac IgG4 [Présence/Seuil] Sérum ; Qualitatif ; Cytométrie de flux | Neurofascine155 As.IgG4 [aanwezigheid] in serum d.m.v. flowcytometrie | ||||||
|
|
Dengue-Virus 1+2+3+4 nsP1 IgG IgG-Antikörper [Nachweis] in Serum oder Plasma mittels Immunoassay | Dengue virus 1+2+3+4 nsP1 IgG antibody, Blood | Dengue virus 1+2+3+4 protéine non structurelle 1 (nsP1) [Présence/Seuil] Sérum/Plasma ; Qualitatif ; Immunoanalyse | Denguevirus 1+2+3+4 niet-structureel proteïne 1 (nsP1) As.IgG [aanwezigheid] in serum of plasma d.m.v. immunoassay | |||||
|
|
|
|
Gaz du sang et ammoniaque panel [-] Sang artériel ; - |
|
|||||
|
|
Cell count and Differential panel, Amniotic fluid |
|
NFS - Hémogramme panel [-] Liquide amniotique ; - ; Comptage manuel | Celtelling & differentieel panel in vruchtwater d.m.v. manuele telling |
|
||||
|
|
|
|
|
|
|||||
| 100850-7 |
|
|
Polynucléaires neutrophiles [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel |
|
|
||||
| 100851-5 | Other cells, Amniotic fluid |
|
Cellules autres [Nombre/Volume] Liquide amniotique ; Numérique ; Comptage manuel | Overige cellen [aantal/volume] in vruchtwater d.m.v. manuele telling |
|
||||
| 100852-3 | NM Bones Views for mets W Sr-89 IV | ||||||||
| 100853-1 | NM Pericardial space | ||||||||
| 100854-9 | Lymphocytes/cells, Blood |
|
Lymphocytes/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique ; Immunoanalyse | Lymfocyten/cellen [getalsfractie] in mononucleaire cellen in bloed d.m.v. immunoassay | |||||
| 100855-6 |
|
CD3/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3/cellen [getalsfractie] in mononucleaire cellen in bloed |
|
|||||
| 100856-4 |
|
CD3+CD4+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3+CD4+/cellen [getalsfractie] in mononucleaire cellen in bloed |
|
|||||
| 100857-2 |
|
CD3+CD8+/100 cellules [Fraction de nombres] Cellules mononucléées de sang périphérique ; Numérique | Cellen.CD3+CD8+/cellen [getalsfractie] in mononucleaire cellen in bloed |
|
|||||
| 100858-0 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4+CD154+/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | |||||
|
|
ST I-Amp 6ms L-I | amplitud inicial del segmento ST, 6 mseg.derivación I:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo I:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-I | |||||
|
|
Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid |
|
|
|
|
||||
| 100860-6 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Spike-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Spike peptide, Blood | CD4 exprimant le TNF alpha/CD4 après stimulation par le peptide Spike de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 spike-peptide [getalsfractie] in bloed | |||||
| 100861-4 | Zellen.CD4+CD154+/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid | Cells.CD4+CD154+ /CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4+CD154+/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4+CD154+/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | |||||
| 100862-2 | Zellen.CD4.Interferon-gamma-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid | Cells.CD4.Interferon gamma-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4 exprimant l'interféron gamma/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.interferon-gamma-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | |||||
| 100863-0 | Zellen.CD4.Tumor-Nekrose-Faktor-alfa-exprimierend/CD4-Zellen in Blut --nach Stimulierung mit SARS-CoV-2-Nukleokapsid-Peptid | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 Cells - after stimulation with SARS-CoV-2 Nucleocapsid peptide, Blood | CD4 exprimant le TNF alpha/CD4 après stimulation par la nucléocapside de coronavirus SARS-CoV-2 [Fraction de nombres] Sang ; Numérique | Cellen.CD4.tumornecrosefactor alfa-positief/cellen.CD4^na stimulatie met SARS-CoV-2 nucleocapsidepeptide [getalsfractie] in bloed | |||||
| 100864-8 | Giardia lamblia bg-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia bg gene genotype, Specimen | Giardia lamblia gène bg [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia bg-gen [genotype] d.m.v. moleculair genetisch onderzoek | |||||
| 100865-5 | Avian schistosomes, Specimen | Aviaire Schistosoma DNA [aanwezigheid] d.m.v. probe-detectie | |||||||
| 100866-3 | Febrile antibody profile, Blood | Profil d'anticorps fébriles [-] Sérum ; - | |||||||
|
|
ST I-Amp 6ms L-II | amplitud inicial del segmento ST, 6 mseg.derivación II:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo II:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-II | |||||
|
|
Campylobacter jejuni+coli+lari+upsaliensis Antigen [Nachweis] in Stuhl mittels Immunoassay-Schnelltest | Campylobacter jejuni+coli+lari+upsaliensis antigen, Stool | Campylobacter jejuni+coli+lari+upsaliensis Ag [Présence/Seuil] Selle ; Qualitatif ; Immunoanalyse rapide | Campylobacter jejuni + coli + lari + upsaliensis Ag [aanwezigheid] in feces d.m.v. immunoassay.sneltest | |||||
|
|
Cryptosporidium sp 18S-LC2 rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium sp 18S-LC2 genotype, Specimen | Cryptosporidium ARNr 18S-LC2 [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium sp. 18S-LC2 rRNA [genotype] d.m.v. moleculair genetisch onderzoek | |||||
|
|
Cryptosporidium gp60-Gen [Typ] in Probenmaterial mittels Molekulargenetik |
|
|
|
|
||||
| 100870-5 | Cryptosporidium 18S rRNA [Genotyp] in Probenmaterial mittels Molekulargenetik | Cryptosporidium 18S genotype, Specimen | Cryptosporidium ARNr 18S [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Cryptosporidium 18S rRNA [genotype] d.m.v. moleculair genetisch onderzoek | |||||
| 100871-3 | Giardia lamblia gdh-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia gdh gene genotype, Specimen | Giardia lamblia gène gdh [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia gdh-gen [genotype] d.m.v. moleculair genetisch onderzoek | |||||
| 100872-1 | Bacteria producing polysaccharide from sucrose | Bactérie productrice de polysaccharide du saccharose [Présence/Seuil] Isolat ; Qualitatif | Uit sucrose polysacharideproducerende bacterie [aanwezigheid] in isolaat | ||||||
| 100873-9 | Giardia lamblia tpi-Gen [Genotyp] in Probenmaterial mittels Molekulargenetik | Giardia lamblia tpi gene genotype, Specimen | Giardia lamblia gène tpi [Génotype] Milieux divers ; Résultat nominal ; Biologie moléculaire | Giardia lamblia tpi-gen [genotype] d.m.v. moleculair genetisch onderzoek | |||||
| 100874-7 | Basidiobolus sp, Specimen | Basidiobolus [Présence/Seuil] Milieux divers ; Qualitatif | Basidiobolus sp. [aanwezigheid] | ||||||
| 10087-5 | ST I-Amp 6ms L-III | amplitud inicial del segmento ST, 6 mseg.derivación III:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms plomo III:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-III | |||||
| 100875-4 | Fet Hrt Doc Ltd US |
|
|||||||
| 100876-2 | Fet Hrt Doc US |
|
|||||||
| 100877-0 | US Heart Transesophageal during surgery | ||||||||
| 100878-8 | Endo US study Upr GI Tract Doc | ||||||||
| 100879-6 | US Guided Brst-R Cryoablation | ||||||||
|
|
US Guided Brst-L Cryoablation |
|
|
||||||
|
|
MR Guided Bone Cryoablation | ||||||||
|
|
MR Peritoneum W contr percu | ||||||||
|
|
ST I-Amp 6ms L-V1 |
|
ST amplitud inicial 6 ms cable V1:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | Deprecated ST initial amp 6 ms.lead | |||||
| 100883-8 | MR Guided Kidney-L Bx | ||||||||
| 100884-6 | MR Guided Kidney-R Bx | ||||||||
| 100885-3 | Parapoxvirus , Specimen | Parapoxvirus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Parapoxvirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100886-1 | Orf virus, Specimen | Orf virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Orfvirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100887-9 | Pseudocowpox virus, Specimen | Pseudocowpox virus ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | Pseudokoepokvirus DNA [aanwezigheid] d.m.v. probe-detectie | ||||||
| 100888-7 | Affenpocken-Virus Klade II DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade II, Specimen | Monkeypox virus clade II ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | 'Mpox'-virus clade II DNA [aanwezigheid] d.m.v. probe-detectie | |||||
| 100889-5 | Affenpocken-Virus Klade I DNA [Nachweis] in Probenmaterial mittels Nukleinsäureamplifikation mit Sondendetektion | Monkeypox virus clade I, Specimen | Monkeypox virus clade I ADN [Présence/Seuil] Milieux divers ; Qualitatif ; PCR amplification de cible | 'Mpox'-virus clade I DNA [aanwezigheid] d.m.v. probe-detectie | |||||
|
|
|
|
|
|
|||||
|
|
ST I-Amp 6ms L-V2 | amplitud inicial del segmento ST, 6 mseg.derivación V2:potencial eléctrico (voltaje):punto en el tiempo:corazón:cuantitativo:electrocardiograma | ST amplitud inicial 6 ms. Derivación V2:Corazón :Punto temporal:Elpot:Cuantitativo:EKG | ST I-Amp 6ms L-V2 | |||||
| 100891-1 |
|
|
|
|
|||||
| 100892-9 |
|
|
|
|
|||||
| 100893-7 | Orthopoxvirus IgG & IgM Ab panel, Blood | Orthopoxvirus IgG et IgM Ac panel [-] Sérum/Plasma ; - | Orthopoxvirus IgG & IgM As panel in serum of plasma | ||||||
| 100894-5 | Recommended screen freq | ||||||||
| 100895-2 |
|
|
|
||||||
| 100896-0 |
|
|
Vasopressine T13 après épreuve [Moles/Volume] Plasma ; Numérique |
|
|||||
| 100897-8 | Staphylococcus aureus culture, Specimen | Staphylococcus aureus [Présence/Seuil] Milieux divers ; Qualitatif ; Culture spécifique | Staphylococcus aureus [aanwezigheid] d.m.v. organisme-specifieke kweek |
|
|||||
| 100898-6 | Lipid panel, Blood | Lipide panel [-] Sérum/Plasma ; - | Lipiden panel in serum of plasma | ||||||
| 100899-4 | Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype culture, Specimen | Enterobacteriaceae phénotype de résistance aux bêta lactamases à spectre élargi [Identification] Milieux divers ; Résultat nominal ; Culture spécifique | Enterobacteriaceae.ESBL-resistentie fenotype [identificator] d.m.v. organisme-specifieke kweek |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
FHIR
®©
HL7.org
2011+.
FHIR
R5
hl7.fhir.core#5.0.0
R6
hl7.fhir.core#6.0.0-ballot3
generated
on
Sun,
Mar
26,
2023
15:23+1100.
Tue,
Apr
1,
2025
12:23+1100.
Links:
Search
|
Version
History
|
Contents
|
Glossary
|
QA
|
Compare
to
R4
|
Compare
to
R4B
R5
|
|
Propose
a
change